JPH09315987A - Utilization of awamori as antiallergic active ingredient - Google Patents
Utilization of awamori as antiallergic active ingredientInfo
- Publication number
- JPH09315987A JPH09315987A JP8153162A JP15316296A JPH09315987A JP H09315987 A JPH09315987 A JP H09315987A JP 8153162 A JP8153162 A JP 8153162A JP 15316296 A JP15316296 A JP 15316296A JP H09315987 A JPH09315987 A JP H09315987A
- Authority
- JP
- Japan
- Prior art keywords
- awamori
- acid
- oil
- rice
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020054 awamori Nutrition 0.000 title claims abstract description 67
- 239000004480 active ingredient Substances 0.000 title claims abstract description 35
- 230000003266 anti-allergic effect Effects 0.000 title claims abstract description 25
- 239000003814 drug Substances 0.000 claims abstract description 36
- 229940079593 drug Drugs 0.000 claims abstract description 26
- 235000013305 food Nutrition 0.000 claims abstract description 21
- 239000002537 cosmetic Substances 0.000 claims abstract description 15
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 36
- 235000007164 Oryza sativa Nutrition 0.000 abstract description 14
- 235000009566 rice Nutrition 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 13
- 208000026935 allergic disease Diseases 0.000 abstract description 10
- 238000000855 fermentation Methods 0.000 abstract description 7
- 230000004151 fermentation Effects 0.000 abstract description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 6
- 235000013334 alcoholic beverage Nutrition 0.000 abstract description 6
- 230000032683 aging Effects 0.000 abstract description 3
- 241001513093 Aspergillus awamori Species 0.000 abstract description 2
- 240000006439 Aspergillus oryzae Species 0.000 abstract description 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 abstract description 2
- 241000233866 Fungi Species 0.000 abstract description 2
- 240000008467 Oryza sativa Japonica Group Species 0.000 abstract description 2
- 206010041349 Somnolence Diseases 0.000 abstract description 2
- 230000001476 alcoholic effect Effects 0.000 abstract description 2
- 238000004821 distillation Methods 0.000 abstract description 2
- 238000003801 milling Methods 0.000 abstract description 2
- 238000010025 steaming Methods 0.000 abstract description 2
- 230000004304 visual acuity Effects 0.000 abstract description 2
- 241000209094 Oryza Species 0.000 abstract 5
- 241000122821 Aspergillus kawachii Species 0.000 abstract 1
- 208000032140 Sleepiness Diseases 0.000 abstract 1
- 235000019631 acid taste sensations Nutrition 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 230000037321 sleepiness Effects 0.000 abstract 1
- -1 leukotriene [metabolite of arachidonic acid Chemical class 0.000 description 75
- 239000000341 volatile oil Substances 0.000 description 54
- 238000002360 preparation method Methods 0.000 description 47
- 239000000203 mixture Substances 0.000 description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
- 229910052799 carbon Inorganic materials 0.000 description 37
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 34
- 235000002639 sodium chloride Nutrition 0.000 description 25
- 125000000217 alkyl group Chemical group 0.000 description 23
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 22
- 239000000284 extract Substances 0.000 description 20
- 150000003839 salts Chemical class 0.000 description 17
- 239000003795 chemical substances by application Substances 0.000 description 16
- 239000000126 substance Substances 0.000 description 16
- 241000218645 Cedrus Species 0.000 description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 208000024891 symptom Diseases 0.000 description 15
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 206010020751 Hypersensitivity Diseases 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 235000002566 Capsicum Nutrition 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 230000007815 allergy Effects 0.000 description 10
- 240000007594 Oryza sativa Species 0.000 description 9
- 239000004359 castor oil Substances 0.000 description 9
- 235000019438 castor oil Nutrition 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical group OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 8
- 239000002674 ointment Substances 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 7
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 7
- 240000008574 Capsicum frutescens Species 0.000 description 7
- 239000004166 Lanolin Substances 0.000 description 7
- 244000269722 Thea sinensis Species 0.000 description 7
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 7
- 239000000427 antigen Substances 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 239000001390 capsicum minimum Substances 0.000 description 7
- 235000019388 lanolin Nutrition 0.000 description 7
- 229940039717 lanolin Drugs 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 229920002101 Chitin Polymers 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 239000013566 allergen Substances 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 6
- 235000013355 food flavoring agent Nutrition 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- 239000004310 lactic acid Substances 0.000 description 6
- 235000014655 lactic acid Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000006072 paste Substances 0.000 description 6
- 230000003449 preventive effect Effects 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical group OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 5
- 229920001661 Chitosan Polymers 0.000 description 5
- 235000005979 Citrus limon Nutrition 0.000 description 5
- 244000131522 Citrus pyriformis Species 0.000 description 5
- 240000004371 Panax ginseng Species 0.000 description 5
- 244000124853 Perilla frutescens Species 0.000 description 5
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical group OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 230000000172 allergic effect Effects 0.000 description 5
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000008434 ginseng Nutrition 0.000 description 5
- 229920000591 gum Polymers 0.000 description 5
- 229960004488 linolenic acid Drugs 0.000 description 5
- 210000001331 nose Anatomy 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 239000006188 syrup Substances 0.000 description 5
- 235000020357 syrup Nutrition 0.000 description 5
- 239000000052 vinegar Substances 0.000 description 5
- 235000021419 vinegar Nutrition 0.000 description 5
- 239000011787 zinc oxide Substances 0.000 description 5
- 235000014692 zinc oxide Nutrition 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 4
- 241000228245 Aspergillus niger Species 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 241001672694 Citrus reticulata Species 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 244000046052 Phaseolus vulgaris Species 0.000 description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- 208000036071 Rhinorrhea Diseases 0.000 description 4
- 206010039101 Rhinorrhoea Diseases 0.000 description 4
- 241000220317 Rosa Species 0.000 description 4
- 206010048908 Seasonal allergy Diseases 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- XWCYDHJOKKGVHC-UHFFFAOYSA-N Vitamin A2 Chemical compound OCC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C XWCYDHJOKKGVHC-UHFFFAOYSA-N 0.000 description 4
- 244000273928 Zingiber officinale Species 0.000 description 4
- 235000006886 Zingiber officinale Nutrition 0.000 description 4
- 235000011054 acetic acid Nutrition 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 235000008524 evening primrose extract Nutrition 0.000 description 4
- 239000010475 evening primrose oil Substances 0.000 description 4
- 229940089020 evening primrose oil Drugs 0.000 description 4
- 235000019688 fish Nutrition 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 235000008397 ginger Nutrition 0.000 description 4
- 235000021552 granulated sugar Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 239000008159 sesame oil Substances 0.000 description 4
- 235000011803 sesame oil Nutrition 0.000 description 4
- 235000020083 shōchū Nutrition 0.000 description 4
- 206010041232 sneezing Diseases 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 229960002920 sorbitol Drugs 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 229940098465 tincture Drugs 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- 244000283070 Abies balsamea Species 0.000 description 3
- 235000007173 Abies balsamea Nutrition 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 244000144730 Amygdalus persica Species 0.000 description 3
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 3
- 240000006891 Artemisia vulgaris Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 235000018185 Betula X alpestris Nutrition 0.000 description 3
- 235000018212 Betula X uliginosa Nutrition 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 3
- 240000005109 Cryptomeria japonica Species 0.000 description 3
- 244000241257 Cucumis melo Species 0.000 description 3
- 240000008067 Cucumis sativus Species 0.000 description 3
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 235000011201 Ginkgo Nutrition 0.000 description 3
- 244000194101 Ginkgo biloba Species 0.000 description 3
- 235000008100 Ginkgo biloba Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000008708 Morus alba Nutrition 0.000 description 3
- 240000000249 Morus alba Species 0.000 description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 description 3
- 244000170916 Paeonia officinalis Species 0.000 description 3
- 239000006002 Pepper Substances 0.000 description 3
- 235000016761 Piper aduncum Nutrition 0.000 description 3
- 240000003889 Piper guineense Species 0.000 description 3
- 235000017804 Piper guineense Nutrition 0.000 description 3
- 235000008184 Piper nigrum Nutrition 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000009827 Prunus armeniaca Nutrition 0.000 description 3
- 244000018633 Prunus armeniaca Species 0.000 description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 235000006468 Thea sinensis Nutrition 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 3
- 150000001335 aliphatic alkanes Chemical class 0.000 description 3
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000020279 black tea Nutrition 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 235000017803 cinnamon Nutrition 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 3
- 229940093471 ethyl oleate Drugs 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 3
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 3
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 3
- 229960002733 gamolenic acid Drugs 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 235000015110 jellies Nutrition 0.000 description 3
- 239000008274 jelly Substances 0.000 description 3
- 229940033355 lauric acid Drugs 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 239000002808 molecular sieve Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000010664 perilla essential oil Substances 0.000 description 3
- 235000019271 petrolatum Nutrition 0.000 description 3
- 235000021110 pickles Nutrition 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 239000003531 protein hydrolysate Substances 0.000 description 3
- 235000015067 sauces Nutrition 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 235000011076 sorbitan monostearate Nutrition 0.000 description 3
- 239000001587 sorbitan monostearate Substances 0.000 description 3
- 229940035048 sorbitan monostearate Drugs 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 229940011671 vitamin b6 Drugs 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- 229930007845 β-thujaplicin Natural products 0.000 description 3
- FPJHWYCPAOPVIV-VOZMEZHOSA-N (2R,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-5-acetamido-2-(hydroxymethyl)-6-methoxy-3-sulfooxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CO[C@@H]1O[C@H](CO)[C@H](OS(O)(=O)=O)[C@H](O[C@@H]2O[C@H]([C@@H](OC)[C@H](O)[C@H]2O)C(O)=O)[C@H]1NC(C)=O FPJHWYCPAOPVIV-VOZMEZHOSA-N 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- OXQGTIUCKGYOAA-UHFFFAOYSA-N 2-Ethylbutanoic acid Chemical compound CCC(CC)C(O)=O OXQGTIUCKGYOAA-UHFFFAOYSA-N 0.000 description 2
- OVBFMEVBMNZIBR-UHFFFAOYSA-N 2-methylvaleric acid Chemical compound CCCC(C)C(O)=O OVBFMEVBMNZIBR-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 241000512259 Ascophyllum nodosum Species 0.000 description 2
- 239000004857 Balsam Substances 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 240000007436 Cananga odorata Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 240000005250 Chrysanthemum indicum Species 0.000 description 2
- 206010010744 Conjunctivitis allergic Diseases 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- 241000218691 Cupressaceae Species 0.000 description 2
- 235000017788 Cydonia oblonga Nutrition 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229920000045 Dermatan sulfate Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 2
- 206010052140 Eye pruritus Diseases 0.000 description 2
- 240000006927 Foeniculum vulgare Species 0.000 description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 2
- 241000555712 Forsythia Species 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 2
- 240000008397 Ganoderma lucidum Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- 229920002971 Heparan sulfate Polymers 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 235000017309 Hypericum perforatum Nutrition 0.000 description 2
- 240000001549 Ipomoea eriocarpa Species 0.000 description 2
- 235000005146 Ipomoea eriocarpa Nutrition 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 244000165082 Lavanda vera Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 240000000982 Malva neglecta Species 0.000 description 2
- 235000000060 Malva neglecta Nutrition 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000009134 Myrica cerifera Nutrition 0.000 description 2
- 235000010676 Ocimum basilicum Nutrition 0.000 description 2
- 240000007926 Ocimum gratissimum Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 2
- 241001290151 Prunus avium subsp. avium Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 244000046146 Pueraria lobata Species 0.000 description 2
- 235000010575 Pueraria lobata Nutrition 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 235000017304 Ruaghas Nutrition 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical class [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 244000061457 Solanum nigrum Species 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 241000270666 Testudines Species 0.000 description 2
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 235000008853 Zanthoxylum piperitum Nutrition 0.000 description 2
- 244000131415 Zanthoxylum piperitum Species 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 208000002205 allergic conjunctivitis Diseases 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000000043 antiallergic agent Substances 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 229960003121 arginine Drugs 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- 208000024998 atopic conjunctivitis Diseases 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 210000003651 basophil Anatomy 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- 229960001950 benzethonium chloride Drugs 0.000 description 2
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 2
- 239000012964 benzotriazole Substances 0.000 description 2
- BJFLSHMHTPAZHO-UHFFFAOYSA-N benzotriazole Chemical compound [CH]1C=CC=C2N=NN=C21 BJFLSHMHTPAZHO-UHFFFAOYSA-N 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 229910052794 bromium Chemical group 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 229940105847 calamine Drugs 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- UCTLRSWJYQTBFZ-DDPQNLDTSA-N cholesta-5,7-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC=C21 UCTLRSWJYQTBFZ-DDPQNLDTSA-N 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229940107161 cholesterol Drugs 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229940051593 dermatan sulfate Drugs 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229960002061 ergocalciferol Drugs 0.000 description 2
- DNVPQKQSNYMLRS-APGDWVJJSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-APGDWVJJSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 2
- 235000008995 european elder Nutrition 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 229960002449 glycine Drugs 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- QBKSWRVVCFFDOT-UHFFFAOYSA-N gossypol Chemical class CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(C=3C(O)=C4C(C=O)=C(O)C(O)=C(C4=CC=3C)C(C)C)=C(C)C=C21 QBKSWRVVCFFDOT-UHFFFAOYSA-N 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910052864 hemimorphite Inorganic materials 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000001341 hydroxy propyl starch Substances 0.000 description 2
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229940102223 injectable solution Drugs 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 235000020094 liqueur Nutrition 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 235000019799 monosodium phosphate Nutrition 0.000 description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229960002446 octanoic acid Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 235000019175 phylloquinone Nutrition 0.000 description 2
- 239000011772 phylloquinone Substances 0.000 description 2
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 2
- 229960001898 phytomenadione Drugs 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 239000013573 pollen allergen Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 2
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 235000019512 sardine Nutrition 0.000 description 2
- 235000013580 sausages Nutrition 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000001892 vitamin D2 Nutrition 0.000 description 2
- 239000011653 vitamin D2 Substances 0.000 description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 2
- 235000005282 vitamin D3 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical group 0.000 description 2
- 229940021056 vitamin d3 Drugs 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- PDHSAQOQVUXZGQ-JKSUJKDBSA-N (2r,3s)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2h-chromene-5,7-diol Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2OC)=CC=C(O)C(O)=C1 PDHSAQOQVUXZGQ-JKSUJKDBSA-N 0.000 description 1
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- WJTCHBVEUFDSIK-NWDGAFQWSA-N (2r,5s)-1-benzyl-2,5-dimethylpiperazine Chemical class C[C@@H]1CN[C@@H](C)CN1CC1=CC=CC=C1 WJTCHBVEUFDSIK-NWDGAFQWSA-N 0.000 description 1
- 239000001096 (4-ethenyl-1-azabicyclo[2.2.2]octan-7-yl)-(6-methoxyquinolin-4-yl)methanol hydrochloride Substances 0.000 description 1
- VNFXPOAMRORRJJ-UHFFFAOYSA-N (4-octylphenyl) 2-hydroxybenzoate Chemical compound C1=CC(CCCCCCCC)=CC=C1OC(=O)C1=CC=CC=C1O VNFXPOAMRORRJJ-UHFFFAOYSA-N 0.000 description 1
- KAKVFSYQVNHFBS-UHFFFAOYSA-N (5-hydroxycyclopenten-1-yl)-phenylmethanone Chemical compound OC1CCC=C1C(=O)C1=CC=CC=C1 KAKVFSYQVNHFBS-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NNKXWRRDHYTHFP-HZQSTTLBSA-N (r)-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;hydron;dichloride Chemical compound Cl.Cl.C([C@H]([C@H](C1)C=C)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 NNKXWRRDHYTHFP-HZQSTTLBSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- LQXBZWFNAKZUNM-UHFFFAOYSA-N 16-methyl-1-(16-methylheptadecoxy)heptadecane Chemical class CC(C)CCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC(C)C LQXBZWFNAKZUNM-UHFFFAOYSA-N 0.000 description 1
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- BFUUZVKGZFPGEC-UHFFFAOYSA-N 2-(dimethylamino)acetic acid hydrate Chemical compound [OH-].C[NH+](C)CC(O)=O BFUUZVKGZFPGEC-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- UMHYVXGZRGOICM-AUYXYSRISA-N 2-[(z)-octadec-9-enoyl]oxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC\C=C/CCCCCCCC UMHYVXGZRGOICM-AUYXYSRISA-N 0.000 description 1
- DXANYXRZRNXGSC-UHFFFAOYSA-N 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl sulfate Chemical compound CC1=C(CCOS([O-])(=O)=O)SC=[N+]1CC1=CN=C(C)N=C1N DXANYXRZRNXGSC-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- WLOMWJGRCLMZPW-UHFFFAOYSA-N 2-hydroxybenzoic acid;propane-1,2-diol Chemical compound CC(O)CO.OC(=O)C1=CC=CC=C1O WLOMWJGRCLMZPW-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- ZVTDEEBSWIQAFJ-KHPPLWFESA-N 2-hydroxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)O ZVTDEEBSWIQAFJ-KHPPLWFESA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- CDUPASLURGOXGD-UHFFFAOYSA-N 2-propoxybenzaldehyde Chemical compound CCCOC1=CC=CC=C1C=O CDUPASLURGOXGD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- RURHILYUWQEGOS-UHFFFAOYSA-N 3-(4-methylphenyl)prop-2-enoic acid Chemical compound CC1=CC=C(C=CC(O)=O)C=C1 RURHILYUWQEGOS-UHFFFAOYSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- FBMWYZZRSWZLDZ-UHFFFAOYSA-N 4,5-dihydro-1h-imidazol-1-ium;hydroxide Chemical compound O.C1CN=CN1 FBMWYZZRSWZLDZ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- XWNSFEAWWGGSKJ-UHFFFAOYSA-N 4-acetyl-4-methylheptanedinitrile Chemical compound N#CCCC(C)(C(=O)C)CCC#N XWNSFEAWWGGSKJ-UHFFFAOYSA-N 0.000 description 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- XZOYHFBNQHPJRQ-UHFFFAOYSA-N 7-methyloctanoic acid Chemical compound CC(C)CCCCCC(O)=O XZOYHFBNQHPJRQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- RYWSYCQQUDFMAU-UHFFFAOYSA-N Acetomenaphthone Chemical compound C1=CC=C2C(OC(=O)C)=CC(C)=C(OC(C)=O)C2=C1 RYWSYCQQUDFMAU-UHFFFAOYSA-N 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 235000016790 Allium chinense Nutrition 0.000 description 1
- 244000295724 Allium chinense Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 235000003911 Arachis Nutrition 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 241000772998 Arthraxon Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- CFLUVFXTJIEQTE-UHFFFAOYSA-N CCCCCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCCCC Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCCCC CFLUVFXTJIEQTE-UHFFFAOYSA-N 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 235000007571 Cananga odorata Nutrition 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 235000014112 Cassia mimosoides Nutrition 0.000 description 1
- 244000302899 Cassia mimosoides Species 0.000 description 1
- 235000006719 Cassia obtusifolia Nutrition 0.000 description 1
- 244000277285 Cassia obtusifolia Species 0.000 description 1
- KKVZAVRSVHUSPL-GQCTYLIASA-N Cassiastearoptene Chemical compound COC1=CC=CC=C1\C=C\C=O KKVZAVRSVHUSPL-GQCTYLIASA-N 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- DBZHHRPNWDNKNX-UHFFFAOYSA-N Chamazulen Natural products CC1=CC=C2C=C(C=CC(=C12)C(C)C)C DBZHHRPNWDNKNX-UHFFFAOYSA-N 0.000 description 1
- GXGJIOMUZAGVEH-UHFFFAOYSA-N Chamazulene Chemical compound CCC1=CC=C(C)C2=CC=C(C)C2=C1 GXGJIOMUZAGVEH-UHFFFAOYSA-N 0.000 description 1
- 244000281762 Chenopodium ambrosioides Species 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 241000209205 Coix Species 0.000 description 1
- 241000272203 Columba Species 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 241000016649 Copaifera officinalis Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000142975 Cornaceae Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 235000009844 Cucumis melo var conomon Nutrition 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- 244000166652 Cymbopogon martinii Species 0.000 description 1
- 235000018791 Cymbopogon nardus Nutrition 0.000 description 1
- 244000166675 Cymbopogon nardus Species 0.000 description 1
- 241001327300 Cymbopogon schoenanthus Species 0.000 description 1
- 241000234646 Cyperaceae Species 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 229920002871 Dammar gum Polymers 0.000 description 1
- 239000004860 Dammar gum Substances 0.000 description 1
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- QSVJYFLQYMVBDR-UHFFFAOYSA-N Ergosterin Natural products C1C(O)CCC2(C)C3=CCC4(C)C(C(C)C=CC(C)C(C)C)CCC4C3=CC=C21 QSVJYFLQYMVBDR-UHFFFAOYSA-N 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 241000195620 Euglena Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical class N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 241000288140 Gruiformes Species 0.000 description 1
- 241000147041 Guaiacum officinale Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 240000008669 Hedera helix Species 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical class OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000282375 Herpestidae Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- 244000267823 Hydrangea macrophylla Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- 102000009438 IgE Receptors Human genes 0.000 description 1
- 108010073816 IgE Receptors Proteins 0.000 description 1
- 241000519695 Ilex integra Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- 240000003483 Leersia hexandra Species 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 240000003394 Malpighia glabra Species 0.000 description 1
- 235000014837 Malpighia glabra Nutrition 0.000 description 1
- 235000013939 Malva Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- YBHQCJILTOVLHD-YVMONPNESA-N Mirin Chemical compound S1C(N)=NC(=O)\C1=C\C1=CC=C(O)C=C1 YBHQCJILTOVLHD-YVMONPNESA-N 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 235000014631 Myrica rubra Nutrition 0.000 description 1
- 244000132436 Myrica rubra Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 240000007695 Nandina domestica Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000002582 Oryza sativa Indica Group Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 241001282110 Pagrus major Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 244000062780 Petroselinum sativum Species 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- 244000064622 Physalis edulis Species 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000016067 Polianthes tuberosa Nutrition 0.000 description 1
- 244000014047 Polianthes tuberosa Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004153 Potassium bromate Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 244000007021 Prunus avium Species 0.000 description 1
- 235000010401 Prunus avium Nutrition 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 235000002357 Ribes grossularia Nutrition 0.000 description 1
- 244000171263 Ribes grossularia Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 235000003142 Sambucus nigra Nutrition 0.000 description 1
- 240000006028 Sambucus nigra Species 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 241000580955 Sapindus mukorossi Species 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 241000543810 Sasa veitchii Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Chemical class OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Chemical class C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical class C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 241000689674 Soleirolia Species 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 241001092387 Spiraea Species 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- QHOPXUFELLHKAS-UHFFFAOYSA-N Thespesin Chemical class CC(C)c1c(O)c(O)c2C(O)Oc3c(c(C)cc1c23)-c1c2OC(O)c3c(O)c(O)c(C(C)C)c(cc1C)c23 QHOPXUFELLHKAS-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000736892 Thujopsis dolabrata Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 235000007769 Vetiveria zizanioides Nutrition 0.000 description 1
- 244000284012 Vetiveria zizanioides Species 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 241001222097 Xenocypris argentea Species 0.000 description 1
- 241000269959 Xiphias gladius Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- OYCUCVYCOQBTLP-UHFFFAOYSA-J [Ti+4].[O-]C(=O)c1ccccc1[O-].[O-]C(=O)c1ccccc1[O-] Chemical compound [Ti+4].[O-]C(=O)c1ccccc1[O-].[O-]C(=O)c1ccccc1[O-] OYCUCVYCOQBTLP-UHFFFAOYSA-J 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- DPRNENKPXAZQBI-UHFFFAOYSA-N alpha-Vitamin A Natural products OCC=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C DPRNENKPXAZQBI-UHFFFAOYSA-N 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940103272 aluminum potassium sulfate Drugs 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000010407 ammonium alginate Nutrition 0.000 description 1
- 239000000728 ammonium alginate Substances 0.000 description 1
- KPGABFJTMYCRHJ-YZOKENDUSA-N ammonium alginate Chemical compound [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 235000003484 annual ragweed Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 210000000612 antigen-presenting cell Anatomy 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical class CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 150000001565 benzotriazoles Chemical class 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 150000001615 biotins Chemical class 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 201000001383 blood group incompatibility Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 235000006263 bur ragweed Nutrition 0.000 description 1
- QGHSAIVADXXKSX-JXMROGBWSA-N butyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCCOC(=O)\C=C\C1=CC=C(OC)C=C1 QGHSAIVADXXKSX-JXMROGBWSA-N 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 229940078456 calcium stearate Drugs 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 229940105289 carbon black Drugs 0.000 description 1
- 235000019241 carbon black Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000013709 carrot oil Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical class CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid group Chemical class C(C=CC1=CC=CC=C1)(=O)O WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 235000003488 common ragweed Nutrition 0.000 description 1
- 230000024203 complement activation Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 229940013361 cresol Drugs 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 235000011950 custard Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- SIYLLGKDQZGJHK-UHFFFAOYSA-N dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium Chemical class C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 SIYLLGKDQZGJHK-UHFFFAOYSA-N 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 239000003221 ear drop Substances 0.000 description 1
- 229940047652 ear drops Drugs 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- VMKSKORGKQPVAO-SECBINFHSA-N ethyl 3-[[(2S)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoate Chemical compound CCOC(=O)CCNC(=O)[C@@H](O)C(C)(C)CO VMKSKORGKQPVAO-SECBINFHSA-N 0.000 description 1
- DHNGCHLFKUPGPX-UHFFFAOYSA-N ethyl 4-methoxycinnamate Natural products CCOC(=O)C=CC1=CC=C(OC)C=C1 DHNGCHLFKUPGPX-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- DHNGCHLFKUPGPX-RMKNXTFCSA-N ethyl trans-p-methoxycinnamate Chemical compound CCOC(=O)\C=C\C1=CC=C(OC)C=C1 DHNGCHLFKUPGPX-RMKNXTFCSA-N 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000010643 fennel seed oil Substances 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 201000005298 gastrointestinal allergy Diseases 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 229930000755 gossypol Chemical class 0.000 description 1
- 229950005277 gossypol Drugs 0.000 description 1
- 229940091561 guaiac Drugs 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000003722 gum benzoin Chemical class 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- GQXQIRNPJBUEGY-UHFFFAOYSA-N hexadecan-7-yl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(C)(C)CCCCCC GQXQIRNPJBUEGY-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 150000004001 inositols Chemical class 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000014705 isoleucine Nutrition 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229960000829 kaolin Drugs 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- DBTMGCOVALSLOR-VPNXCSTESA-N laminarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)C(O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VPNXCSTESA-N 0.000 description 1
- IZWSFJTYBVKZNK-UHFFFAOYSA-N lauryl sulfobetaine Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-N 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229940105112 magnesium myristate Drugs 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- DMRBHZWQMKSQGR-UHFFFAOYSA-L magnesium;tetradecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O DMRBHZWQMKSQGR-UHFFFAOYSA-L 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229940100434 menadiol Drugs 0.000 description 1
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229960003926 methylrosaniline Drugs 0.000 description 1
- QFVDKARCPMTZCS-UHFFFAOYSA-N methylrosaniline Chemical compound C1=CC(N(C)C)=CC=C1C(O)(C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 QFVDKARCPMTZCS-UHFFFAOYSA-N 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- ONLRKTIYOMZEJM-UHFFFAOYSA-N n-methylmethanamine oxide Chemical compound C[NH+](C)[O-] ONLRKTIYOMZEJM-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- KKVZAVRSVHUSPL-UHFFFAOYSA-N o-methoxycinnamic aldehyde Natural products COC1=CC=CC=C1C=CC=O KKVZAVRSVHUSPL-UHFFFAOYSA-N 0.000 description 1
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- YYZUSRORWSJGET-UHFFFAOYSA-N octanoic acid ethyl ester Chemical class CCCCCCCC(=O)OCC YYZUSRORWSJGET-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000008183 oral pharmaceutical preparation Substances 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 150000002948 pantothenic acids Chemical class 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229920001277 pectin Chemical class 0.000 description 1
- 239000001814 pectin Chemical class 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 239000004584 polyacrylic acid Chemical class 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 1
- 235000010408 potassium alginate Nutrition 0.000 description 1
- 239000000737 potassium alginate Substances 0.000 description 1
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 235000019396 potassium bromate Nutrition 0.000 description 1
- 229940094037 potassium bromate Drugs 0.000 description 1
- PYJBVGYZXWPIKK-UHFFFAOYSA-M potassium;tetradecanoate Chemical compound [K+].CCCCCCCCCCCCCC([O-])=O PYJBVGYZXWPIKK-UHFFFAOYSA-M 0.000 description 1
- 235000012029 potato salad Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- XATKDVHSLQMHSY-UHFFFAOYSA-N propan-2-yl 3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(C=CC(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 229940010310 propylene glycol dioleate Drugs 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 229940062251 propylene glycol salicylate Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960001811 quinine hydrochloride Drugs 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 235000009736 ragweed Nutrition 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003870 salicylic acids Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910000338 selenium disulfide Inorganic materials 0.000 description 1
- JNMWHTHYDQTDQZ-UHFFFAOYSA-N selenium sulfide Chemical compound S=[Se]=S JNMWHTHYDQTDQZ-UHFFFAOYSA-N 0.000 description 1
- 229960005265 selenium sulfide Drugs 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Chemical class 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000001632 sodium acetate Chemical class 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007974 sodium acetate buffer Chemical class 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- XUXNAKZDHHEHPC-UHFFFAOYSA-M sodium bromate Chemical compound [Na+].[O-]Br(=O)=O XUXNAKZDHHEHPC-UHFFFAOYSA-M 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- FVEFRICMTUKAML-UHFFFAOYSA-M sodium tetradecyl sulfate Chemical compound [Na+].CCCCC(CC)CCC(CC(C)C)OS([O-])(=O)=O FVEFRICMTUKAML-UHFFFAOYSA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- MZSDGDXXBZSFTG-UHFFFAOYSA-M sodium;benzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=CC=C1 MZSDGDXXBZSFTG-UHFFFAOYSA-M 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940100515 sorbitan Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000021335 sword fish Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003784 tall oil Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- IFYFNVDTVZKNBZ-UHFFFAOYSA-N tetradecyl 2-hydroxybenzoate Chemical compound CCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1O IFYFNVDTVZKNBZ-UHFFFAOYSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- QIWDGSYHBCMXSI-UHFFFAOYSA-J tetrasodium;(2-methyl-4-phosphonatooxynaphthalen-1-yl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].C1=CC=CC2=C(OP([O-])([O-])=O)C(C)=CC(OP([O-])([O-])=O)=C21 QIWDGSYHBCMXSI-UHFFFAOYSA-J 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000012929 tonicity agent Substances 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- 229960001005 tuberculin Drugs 0.000 description 1
- 210000001944 turbinate Anatomy 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- GAAKLDANOSASAM-UHFFFAOYSA-N undec-10-enoic acid;zinc Chemical compound [Zn].OC(=O)CCCCCCCCC=C GAAKLDANOSASAM-UHFFFAOYSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical group 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019143 vitamin K2 Nutrition 0.000 description 1
- 239000011728 vitamin K2 Substances 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
- 235000012773 waffles Nutrition 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229960003434 xenysalate Drugs 0.000 description 1
- HLDCSYXMVXILQC-UHFFFAOYSA-N xenysalate Chemical compound CCN(CC)CCOC(=O)C1=CC=CC(C=2C=CC=CC=2)=C1O HLDCSYXMVXILQC-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229940098697 zinc laurate Drugs 0.000 description 1
- 229940012185 zinc palmitate Drugs 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- 229940057977 zinc stearate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229940118257 zinc undecylenate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 description 1
- GPYYEEJOMCKTPR-UHFFFAOYSA-L zinc;dodecanoate Chemical compound [Zn+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O GPYYEEJOMCKTPR-UHFFFAOYSA-L 0.000 description 1
- GJAPSKMAVXDBIU-UHFFFAOYSA-L zinc;hexadecanoate Chemical compound [Zn+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O GJAPSKMAVXDBIU-UHFFFAOYSA-L 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、泡盛を抗アレルギ
ー有効成分とする食品、医薬品、医薬部外品及び、化粧
品に関する。TECHNICAL FIELD The present invention relates to foods, pharmaceuticals, quasi drugs, and cosmetics containing awamori as an antiallergic active ingredient.
【0002】[0002]
【従来の技術】アレルギー性疾患を引き起こすアレルギ
ーは次のI〜IV型の4種類に大別されている。I 型ア
レルギー(即時型アレルギー)は、抗原の再侵入により
比較的短時間に発症するものをいい、花粉症、アレルギ
ー性鼻炎、アトピー性皮膚炎、喘息、蕁麻疹、湿疹、胃
腸アレルギー等は、この反応によるものである。II型ア
レルギー(細胞障害性過敏症反応)は、細胞表層上に存
在する抗原に抗体が結合し誘発される反応であり、輸血
時の血液型不適合の際に起こる副作用や、全身性紅斑性
狼瘡(SLE)など自己免疫病の主因となっている。II
I 型アレルギーは、抗原の生体侵入から数時間または数
日後に抗原−抗体複合体が生体内で沈降し、血管壁に沈
着して、ここで補体を活性化することによって発症する
急性炎症をいう。IV型アレルギー(遅延型過敏症反応)
は、免疫の成立した個体に再度抗原を投与すると、24
〜48時間後に最高に達する硬結を伴う炎症反応を言
い、ツベルクリン反応や移植片拒絶反応などがこれにあ
たる。2. Description of the Related Art Allergies that cause allergic diseases are roughly classified into the following four types I to IV. Type I allergies (immediate allergies) are those that develop in a relatively short time due to re-invasion of the antigen, and hay fever, allergic rhinitis, atopic dermatitis, asthma, urticaria, eczema, gastrointestinal allergy, etc. This is due to this reaction. Type II allergy (cytotoxic hypersensitivity reaction) is a reaction that is induced by binding of an antibody to an antigen present on the cell surface layer, which is a side effect that occurs during blood group incompatibility during transfusion and systemic lupus erythematosus. (SLE) is a major cause of autoimmune diseases. II
Type I allergy is an acute inflammation that occurs when the antigen-antibody complex precipitates in vivo and deposits on the blood vessel wall several hours or days after the invasion of the antigen into the body, where complement activation activates. Say. Type IV allergy (delayed hypersensitivity reaction)
When the immunized individual is re-administered with the antigen,
After 48 hours, it means an inflammatory reaction with induration that reaches the maximum, and examples thereof include tuberculin reaction and graft rejection reaction.
【0003】これら4種類のアレルギーの中で、I 型ア
レルギーに分類されるものは、近年、その増加が著し
く、この傾向は、大気汚染、食生活の変化(例えば、リ
ノール酸の過剰摂取による体内脂肪酸のバランスの崩
れ)及び、医薬品や化粧品に使用され人体に取り込まれ
たり接触する機会の多い種々の合成化合物などによる生
活環境の変化によるものと考えられている。アレルギー
症状を引き起こす原因物質はアレルゲンと呼ばれる。ス
ギ、ヒノキ、シラカバ、ブタクサ、ホソムギなどの花粉
は空中に飛散して、花粉症を引き起こす花粉アレルゲン
である。これらの花粉アレルゲンの中で重大な社会問題
となっているスギは、目のかゆみ、痛みや充血等のアレ
ルギー性結膜炎、くしゃみや鼻詰まり、鼻水等の鼻アレ
ルギーの症状を呈し、その数は一千万人とも言われてい
る。Among these four types of allergies, those classified as type I allergies have been significantly increasing in recent years, and this tendency is due to air pollution and changes in dietary habits (for example, in the body due to excessive intake of linoleic acid). It is believed that this is caused by a change in the living environment caused by the imbalance of fatty acids) and various synthetic compounds that are often used in pharmaceuticals and cosmetics and are often taken into contact with the human body or come into contact with them. The causative agent that causes allergic symptoms is called an allergen. Pollens such as cedar, cypress, birch, ragweed, and barley are airborne pollen allergens that cause hay fever. Among these pollen allergens, cedar, which has become a serious social problem, has symptoms of allergic conjunctivitis such as itchy eyes, pain and redness, sneezing and stuffy nose, and runny nose. It is also said to be 10 million.
【0004】花粉症を含めて、I 型アレルギー発症にI
gE抗体(免疫グロブリンE)が重要な役割を演じてい
る。I 型アレルギーの発症機序は、大きく次の3段階に
分けられる。 第1段階:ヒト体内に侵入したアレルゲンはマクロファ
ージなどの抗原提示細胞に取り込まれ分解されてペプチ
ドとなる。このペプチドの一部(T細胞が認識するエピ
トープ)は自己のMHCタンパクと複合体を形成し、T
細胞にその抗原性を伝え、T細胞を活性化する。活性化
されたT細胞は種々のサイトカインを放出し、これらの
サイトカインはB細胞に作用してB細胞の分化、増殖を
促し、アレルゲン特異的なIgE抗体を産生する。産生
されたIgE抗体は標的細胞である皮膚、粘膜に存在す
る肥満細胞や末梢血に存在する好塩基球の細胞表面に存
在するIgEレセプターに結合して感作状態が成立す
る。 第2段階:再び侵入したアレルゲンは感作状態の細胞表
面で2分子以上のIgE抗体と結合し、アレルゲンを介
して架橋構造を形成する。この架橋構造の形成が引き金
となって肥満細胞や好塩基球に多量含まれるヒスタミン
や、ロイコトリエン[アラキドン酸(炭素数20の不飽
和脂肪酸)のリポキシゲナーゼによる代謝物]等の化学
伝達物質が遊離する。 第3段階:遊離したこれらの化学伝達物質は平滑筋の収
縮や毛細血管透過性の増加をもたらし、前記の種々のア
レルギー症状を発症する。アレルギー症状の発症自体
は、抗原(細菌、ウイルス等)が侵入した局所に障害的
な病変を起こしても、抗原の全身への侵入を防ぎ、抗原
を排除するという観点からは、体の防御反応の現れであ
る。しかしながら、最近、局所的又は全身的なアレルギ
ー性疾患を訴える人が非常に増加している。For the development of type I allergy, including hay fever
The gE antibody (immunoglobulin E) plays an important role. The onset mechanism of type I allergy can be broadly divided into the following three stages. First step: The allergen invading the human body is taken up by antigen-presenting cells such as macrophages and decomposed into peptides. Part of this peptide (an epitope recognized by T cells) forms a complex with its own MHC protein,
It transmits its antigenicity to cells and activates T cells. Activated T cells release various cytokines, and these cytokines act on B cells to promote B cell differentiation and proliferation, and produce allergen-specific IgE antibodies. The produced IgE antibody binds to the IgE receptor present on the cell surface of the target cells, mast cells present in the skin and mucous membranes and basophils present in peripheral blood, to establish a sensitized state. Second step: The re-invaded allergen binds to two or more molecules of IgE antibody on the surface of the sensitized cell and forms a crosslinked structure via the allergen. The formation of this crosslinked structure triggers release of chemical mediators such as histamine, which is contained in large amounts in mast cells and basophils, and leukotriene [metabolite of arachidonic acid (an unsaturated fatty acid having 20 carbon atoms) by lipoxygenase]. . Third stage: These released chemical messengers cause contraction of smooth muscle and increase in capillary permeability, and the various allergic symptoms described above are developed. The onset of allergic symptom itself is a defense reaction of the body from the viewpoint of preventing the invasion of the antigen into the whole body and eliminating the antigen, even if a locally impaired lesion caused by invasion of the antigen (bacteria, virus, etc.) occurs. Is a manifestation of. However, recently, the number of people who complain of local or systemic allergic diseases has greatly increased.
【0005】既に、合成化合物が抗アレルギー剤の有効
成分として使用されており、現在も種々の抗アレルギー
作用を有する合成化合物が提案されている。しかしなが
ら、現在用いられている抗アレルギー剤の中には、眠
気、咽頭乾燥感、視力低下などの副作用を示すものがあ
り、特に大衆薬に使用されている場合には、その性質が
周知されているとは言い難いために使用に際して不便を
生ずることがある。他方、植物もしくは、その抽出物か
ら抗アレルギー有効成分を見いだす努力も精力的になさ
れており、既に種々の提案が行われており、例えば、次
のような提案がある。未成熟のウンシュウミカンの抽出
物(特開昭63-170323 号公報)。テンチャ(甜茶)の抽
出物(特開平6-192114号公報)。ウコンの抽出物(特開
平6-211713号公報)。カヤツリグサの抽出物(特開平7-
53359 号公報)。コメの抽出物(特開平7-252158号公
報)。コンフリーの抽出物(特開平7-278001号公報)。
α−リノレン酸含有エゴマ油とセサミン含有ゴマ油の混
合物(特開平4-290822号公報)。γ−リノレン酸含有月
見草油(特開平5-68506 号公報)。アマチャヅルの焼酎
抽出物(1987年05月24日付東京読売新聞朝刊日曜版7
面)。バラの焼酎抽出物(特開平4-108708号公報)。し
かしながら、現在もなお、アレルギー性疾患に予防効果
及び、治療効果を有する新しい有効成分の提案が熱望さ
れている。Synthetic compounds have already been used as active ingredients of antiallergic agents, and synthetic compounds having various antiallergic actions have been proposed at present. However, some of the currently used anti-allergic agents have side effects such as drowsiness, dryness of the throat, and decreased visual acuity, and their properties are well known, especially when they are used in over-the-counter drugs. Since it is difficult to say that it is present, it may cause inconvenience in use. On the other hand, efforts to find an antiallergic active ingredient from a plant or its extract have been energetically made, and various proposals have already been made. For example, there are the following proposals. An extract of immature Unshiu mandarin (Japanese Patent Application Laid-Open No. 63-170323). Extract of tencha (Japanese tea) (JP-A-6-192114). Turmeric extract (JP-A-6-211713). Extracts of Cyperaceae (JP-A-7-
53359 publication). Extract of rice (JP-A-7-252158). Comfrey extract (JP-A-7-278001).
A mixture of α-linolenic acid-containing sesame oil and sesamin-containing sesame oil (JP-A-4-290822). Evening primrose oil containing γ-linolenic acid (JP-A-5-68506). Shochu extract of Japanese armored crane (Tokyo Yomiuri Shimbun morning edition Sunday May 24, 1987 7
surface). Rose shochu extract (JP-A-4-108708). However, even now, proposals for new active ingredients having preventive and therapeutic effects on allergic diseases are still eagerly desired.
【0006】[0006]
【発明が解決しようとする課題】そこで、本発明者ら
は、その性質が十分に周知されていて、日常的に摂取さ
れている食品の中から抗アレルギー有効成分を見いだす
こと、これを抗アレルギー有効成分とする食品、医薬
品、医薬部外品及び、化粧品を提供することを課題とし
た。Therefore, the present inventors have found out an antiallergic active ingredient from foods which are well known for their properties and which are ingested on a daily basis. It was an object to provide foods, pharmaceuticals, quasi-drugs, and cosmetics as active ingredients.
【0007】[0007]
【課題を解決するための手段】本発明者らは、鋭意努力
を重ねた結果、泡盛が抗アレルギー有効成分として利用
できること及び、泡盛を抗アレルギー有効成分とする食
品、医薬品、医薬部外品及び、化粧品を提案するに到っ
た。本発明はこのようにして完成したものである。Means for Solving the Problems As a result of earnest efforts, the present inventors have found that awamori can be used as an antiallergic active ingredient, and that foods, pharmaceuticals, quasi drugs, and quasi-drugs containing awamori as an antiallergic active ingredient can be used. , Came to propose cosmetics. The present invention is thus completed.
【0008】したがって、本発明は次の構成上の特徴を
有する。第1の発明は、泡盛を抗アレルギー有効成分と
する食品に関する。第2の発明は、泡盛を抗アレルギー
有効成分とする医薬品に関する。第3の発明は、泡盛を
抗アレルギー有効成分とする医薬部外品に関する。第4
の発明は、泡盛を抗アレルギー有効成分とする化粧品に
関する。Therefore, the present invention has the following structural features. The first invention relates to a food containing awamori as an antiallergic active ingredient. The second invention relates to a medicine containing awamori as an antiallergic active ingredient. The third invention relates to a quasi drug containing awamori as an antiallergic active ingredient. 4th
The present invention relates to cosmetics containing awamori as an antiallergic active ingredient.
【0009】以下、本発明を詳細に説明する。本発明で
有効成分として使用する泡盛は、もろみ取焼酎の原型に
位置づけられている沖縄県特産の米焼酎であり、蒸米に
黒麹菌(泡盛菌)をはやした酸味の強い麹と水とを容器
に仕込み、糖化と同時に酵母によるアルコール発酵を行
わせた後、蒸留を含む数工程を経る確立された方法で製
造されている。したがって、泡盛は、安定的に入手可能
なアルコール性飲料であり、本発明の抗アレルギー有効
成分として使用することに何の問題もない。使用する蒸
米用の米は、タイ米等のインディカ米もしくは、ジャポ
ニカ米のうるちを、通常、精米して使用する。使用する
黒麹菌を例示すれば、アスペルギルス・アワモリ(黒麹
菌の一種)、アスペルギルス・カワチ(黒麹菌の変異株
で白麹菌の一種)をあげることができる。酵母は、通
常、泡盛酵母と呼ばれる酵母群が使用されている。この
群の中には、その菌学的性質がよく研究されている泡盛
一号酵母が含まれている。アルコール発酵済みの熟成し
た一次もろみを簡単な単式蒸留機で蒸留すると、アルコ
ール分45度[度はアルコール性飲料に使用される単位
で容量%にあたる。化学便覧 基礎編 II(丸善、19
66年、東京)、463頁の表5.42エタノールの濃
度によれば、15.56℃で、45度は、38%にな
る。]に近い原酒が得られる。以下において、この原酒
及びその水希釈物を古酒と区別するために、新酒と記載
する。Hereinafter, the present invention will be described in detail. Awamori used as an active ingredient in the present invention is rice shochu specially produced in Okinawa, which is positioned as the prototype of Moromitori shochu, in which steamed rice is produced with black koji mold (awamori fungus) and strong acidity koji and water. It is manufactured by a well-established method in which a container is charged, alcoholic fermentation with yeast is performed at the same time as saccharification, and then several steps including distillation are performed. Therefore, awamori is an alcoholic beverage that can be stably obtained, and there is no problem in using it as the antiallergic active ingredient of the present invention. The rice for steaming rice to be used is usually Indica rice such as Thai rice, or the moisturizing of Japonica rice, which is used after milling. Examples of Aspergillus niger used include Aspergillus awamori (a kind of Aspergillus niger) and Aspergillus kawachi (a mutant of Aspergillus niger, a kind of Aspergillus niger). As the yeast, a yeast group called Awamori yeast is usually used. This group includes Awamori No. 1 yeast, whose mycological properties have been well studied. When the aged primary mash that has been subjected to alcohol fermentation is distilled with a simple single-distiller, the alcohol content is 45 degrees [degree is the unit used for alcoholic beverages and corresponds to volume%. Chemistry Handbook Basic Edition II (Maruzen, 19
According to the concentration of ethanol in Table 5.42 on page 463, pp. 463, the temperature at 15.56 ° C is 45% at 38%. ] You can get the original sake. In the following, in order to distinguish this original sake and its water dilution from old sake, it is referred to as new sake.
【0010】この原酒を、伝統的方法では、かめにつめ
てイトバショウの葉でくるんだデイコ(マメ科の植物)
の木栓で密栓をして、最近の方法では、ステンレスタン
ク、ホウロウ引きのタンク、樽、ビン等の密閉容器につ
めてラップ等で密栓をして、3〜15年、通常は、3〜
10年程度貯蔵熟成して、色、味及び、香で、新酒より
も優れている古酒と称される泡盛ができあがる。この貯
蔵熟成したものに水を加え、アルコール分40、35、
30、25度の製品に調製されたものを容易に入手する
ことができる。古酒と新酒との色、味及び、香における
相違点の解明を目的とする学術研究が行われている。例
えば、熟成期間中の、香味成分の酸化的条件下での化学
的変化及び、エタノール分子と水分子との相互作用の物
理的変化[醗酵工学会誌、69巻、第4号、237−2
52(1991)]や、カプリル酸(オクタン酸に同
じ)及び、ラウリル酸(ドデカン酸に同じ)の増加[醗
酵工学会誌、64巻、第1号、9−15(1986)]
等についての報告が見られる。According to the traditional method, this sake is packed with turtles and wrapped in leaves of Itoshosho. Deiko (Fabaceae plant)
3 to 15 years, usually 3 to 15 years, usually 3 to 15 years after sealing with a wooden stopper, and in a recent method, sealing in a closed container such as a stainless tank, an enameled tank, a barrel, a bottle, etc.
After aging for about 10 years, awamori called old sake, which is superior to fresh sake in color, taste and aroma, is completed. Water is added to this aged storage product, and the alcohol content is 40, 35,
It is easily available as a product prepared for products at 30 and 25 degrees. Academic research is being conducted to clarify the differences in the color, taste, and aroma between old and new sake. For example, during aging, chemical changes in flavor components under oxidative conditions and physical changes in the interaction between ethanol molecules and water molecules [Fermentation Engineering Journal, Vol. 69, No. 4, 237-2].
52 (1991)] and increase of caprylic acid (same as octanoic acid) and lauric acid (same as dodecanoic acid) [Fermentation Engineering Journal, Volume 64, No. 1, 9-15 (1986)].
There are reports about the above.
【0011】泡盛は、アルコール性飲料としてその性質
が周知されたものであり、その周知された性質にしたが
って使用すれば、本発明の目的に有利に使用できる。本
発明で有効成分として使用する泡盛は、新酒、古酒及
び、この中間に位置する泡盛、新酒と古酒との混合物
等、泡盛であれば、いずれの泡盛も使用することができ
るが、好ましくは、3〜10年程度、より好ましくは、
3〜6年程度貯蔵熟成した古酒を使用する。使用に際し
て、泡盛を水で希釈して使用することも、モレキュラー
シーブ(分子篩い)によって、水及び/または、エタノ
ールの一部を除いて使用することもできる。また、液体
クロマトグラフィーに使用する化学結合型充てん剤[例
えば、シリカゲルの表面にオクタデシルシリル基を結合
させた充てん剤。その中には、SeppakC18が含
まれる]を使用して、水及び/または、エタノールの一
部を除く処理をした泡盛を、抗アレルギー有効成分とし
て使用することもできる。Awamori is well known in its properties as an alcoholic beverage, and if used according to its well known properties, it can be advantageously used for the purpose of the present invention. Awamori used as an active ingredient in the present invention is new liquor, old liquor, and awamori located in the middle thereof, a mixture of fresh liquor and old liquor, and any awamori can be used, but it is preferable. Is about 3 to 10 years, more preferably,
Use old sake that has been stored and aged for about 3 to 6 years. At the time of use, Awamori can be used after diluting it with water or by removing a part of water and / or ethanol with a molecular sieve (molecular sieve). Further, a chemical bond type packing material used for liquid chromatography [for example, a packing material in which octadecylsilyl group is bonded to the surface of silica gel. Among them, Seppak C18 is included], and awamori treated by removing a part of water and / or ethanol can be used as an antiallergic active ingredient.
【0012】泡盛は、抗アレルギー有効成分としてその
ままアルコール性飲料として飲用することができること
は勿論である。さらに、食品、医薬品、医薬部外品、化
粧品などの各種組成物に有利に利用できる。泡盛を抗ア
レルギー有効成分として含有する食品としては、次のも
のを例示することができる。素甘、餅類、まんじゅう、
ういろう、あん類、羊羮、水羊羮、ゼリー、水飴等の半
流動状の飴、飴玉などの各種和菓子。プリン、バターク
リーム、カスタードクリーム、シュークリーム、ワッフ
ル、ボンボン、リキュールスポンジなどの洋菓子。アイ
スクリーム、シャーベットなどの氷菓。果実のシロップ
漬、氷蜜などのシロップ類。フラワーペースト、ピーナ
ッツペースト、フルーツペースト、スプレッドなどのペ
ースト類。ジャム。マーマレード。シロップ漬などの果
実。野菜の加工食品類。福神漬、べったら漬、千枚漬、
らっきょう漬などの漬物類。ハム、ソーセージなどの畜
肉製品類。魚肉ハム、魚肉ソーセージ、かまぼこ、ちく
わ、天ぷらなどの魚肉製品。ウニ、イカの塩辛、酢こん
ぶなどの各種珍味類。のり、山菜、するめ、小魚、貝な
どで製造されるつくだ煮類。煮豆、ポテトサラダ、こん
ぶ巻などの惣菜食品。南蛮酢、焼肉のタレなどの各種調
味料。乳飲料、ヨーグルト、チーズなどの乳製品。魚
肉、畜肉、果実、野菜のビン詰、缶詰類。リキュールな
どの酒類。コーヒー、紅茶、ジュース、乳清飲料、炭酸
飲料、乳酸飲料、乳酸菌飲料などの飲料。更には、離乳
食、治療食、ドリンク剤などの各種飲食物。Of course, awamori can be directly consumed as an alcoholic beverage as an antiallergic active ingredient. Further, it can be advantageously used for various compositions such as foods, pharmaceuticals, quasi drugs, cosmetics and the like. Examples of foods containing awamori as an antiallergic active ingredient include the following. Sweet, mochi, manju,
Uiro, bean paste, yokan, mizuyo, jelly, starch syrup and other semi-liquid candy, and various Japanese sweets such as candy. Western sweets such as pudding, butter cream, custard cream, cream puff, waffles, bonbons, liqueur sponges. Ice cream, sherbet and other frozen desserts. Syrups such as pickled fruits and ice honey. Pastes such as flower paste, peanut paste, fruit paste and spreads. jam. marmalade. Fruits such as syrup pickles. Processed foods of vegetables. Fukugami-zuke, Betara-zuke, Senmai-zuke,
Pickles such as rakkyo pickles. Meat products such as ham and sausage. Fish products such as fish ham, fish sausage, kamaboko, chikuwa, and tempura. Various delicacies such as sea urchin, salted squid, and vinegar kelp. Tsukudani stew made from seaweed, wild vegetables, sardines, small fish and shellfish. Prepared foods such as boiled beans, potato salad, and kelp rolls. Various seasonings such as nanban vinegar and yakiniku sauce. Dairy products such as milk drinks, yogurt and cheese. Bottled and canned fish, meat, fruits and vegetables. Liquors such as liqueurs. Beverages such as coffee, tea, juice, whey drinks, carbonated drinks, lactic acid drinks and lactic acid bacteria drinks. Furthermore, various foods and drinks such as baby foods, therapeutic foods and drinks.
【0013】泡盛を抗アレルギー有効成分として含有す
る医薬品は、経口剤としても、非経口剤としても使用で
きる。非経口剤では、器官に直接使用する剤であって
も、外用剤であってもよい。経口剤の製剤として、次に
ような製剤をあげることができる。エキス剤、エマルシ
ョン剤、エリキシル剤、カプセル剤、シロップ剤、ソフ
トカプセル剤、マイクロカプセル剤、液剤、懸濁剤、乳
剤、流エキス剤。非経口剤は、点鼻薬、点眼薬、点耳
薬、インサート剤(鼻、耳)、嗅剤(=嗅入剤、吸入
剤。鼻、喉、気管支)、注射(静脈内、皮下、筋肉内、
経皮、直腸内)及び、座薬(膣、直腸、肛門)のように
器官に対して直接使用することも、外用剤として使用す
ることも、これらの両方を兼ねたような使用方法で用い
ることもできる。非経口剤の製剤として、次にような製
剤をあげることができる。エアゾール剤、エマルション
剤、カプセル剤、クリーム剤、ゲル剤、スプレ−剤、ゼ
リー剤、チンキ剤、パスタ剤、ペースト剤、リニメント
剤、ローション剤、液剤、懸濁剤、膏薬剤、貼付剤、軟
膏剤、乳剤、噴霧剤。The drug containing awamori as an antiallergic active ingredient can be used as an oral preparation or a parenteral preparation. Parenteral agents may be agents for direct use on the organ or external preparations. Examples of oral preparations include the following preparations. Extract, emulsion, elixir, capsule, syrup, soft capsule, microcapsule, solution, suspension, emulsion, flow extract. Parenteral preparations include nasal drops, eye drops, ear drops, inserts (nose, ear), olfactory agents (= snuff agents, inhalants; nose, throat, bronchi), injections (intravenous, subcutaneous, intramuscular). ,
Transdermal, intrarectal) and suppositories (vaginal, rectal, anus) direct use on organs, external use, or both. You can also Examples of the parenteral preparations include the following preparations. Aerosol, emulsion, capsule, cream, gel, spray, jelly, tincture, pasta, paste, liniment, lotion, solution, suspension, salve, patch, ointment Agents, emulsions, sprays.
【0014】本発明の有効成分は、医薬部外品に有効成
分として添加しても利用できる。頭髪に使用する製剤に
は、シャンプー、リンス、ヘアトリートメント、育毛・
養毛料などの頭髪化粧料(ヘアエッセンス剤、ヘアトニ
ック、整髪料)及び、オイルがある。口腔用組成物の剤
型には、うがいぐすり、歯磨きがある。浴用に使用する
剤型には、入浴剤、ボディーソープがある。さらに、ウ
エットティシュに担持させることもできる。The active ingredient of the present invention can be used by adding it to a quasi drug as an active ingredient. Formulations used for hair include shampoo, conditioner, hair treatment, hair growth,
There are hair cosmetics such as hair nourishing agents (hair essence agents, hair tonics, hair styling agents), and oils. The dosage form of the oral composition includes gargling and toothpaste. Dosage forms used for bath include bath salts and body soaps. Further, it can be carried on a wet tissue.
【0015】本発明の有効成分は、化粧品に有効成分と
して添加しても利用できる。化粧品の剤型には、化粧
水、乳液、クリーム、ローション、洗顔料、皮膚洗浄
料、クレンジングクリーム、パック、化粧クリーム、軟
膏等がある。The active ingredient of the present invention can also be used by adding it to cosmetics as an active ingredient. Cosmetic formulations include lotions, emulsions, creams, lotions, facial cleansers, skin cleansers, cleansing creams, packs, cosmetic creams, ointments and the like.
【0016】これら、食品、医薬品、医薬部外品、化粧
品に用いられる組成物として、本発明の有効成分である
泡盛をそのまま用いることができる。さらに、本発明に
よる有効成分の効果を損なわず、相加的もしくは相乗的
に、効果をより確実に発揮させる物質を含む組成物とし
て使用することもできる。これらの効果の発現を支援す
る物質は組成物における使用目的で分類することが可能
であり、次のようなものを例示することができる。pH
調整剤、ゲル基剤、ベヒクル、安定剤、液状担体、可溶
化剤、界面活性剤、滑沢剤、甘味剤、緩衝剤、吸収促進
剤、矯香剤、矯臭剤、矯味剤、結合剤、懸濁化剤、抗酸
化剤、香味剤、香料、高分子増粘剤、固形担体、殺菌
剤、酸化防止剤、紫外線吸収剤、湿潤剤、潤滑剤、色
素、親水性基剤、水溶性基剤、清涼化剤、疎水性基剤、
相溶化剤、増粘剤、増量剤、担体、着香料、着色剤、添
加剤、等張化剤、軟膏基剤、乳化剤、乳剤性基剤、被覆
剤、賦形剤、風味剤、分散剤、噴射剤、保湿剤、保存
剤、補助剤、崩壊剤、崩壊助剤、崩壊抑制剤、膨化剤、
防腐・殺菌剤、防腐剤、無痛化剤、油性基剤、溶解補助
剤、溶剤、流動性促進剤。Awamori, which is the active ingredient of the present invention, can be used as it is as a composition used in these foods, pharmaceuticals, quasi drugs, and cosmetics. Furthermore, it can be used as a composition containing a substance that exerts the effect more reliably additively or synergistically without impairing the effect of the active ingredient according to the present invention. The substances that support the manifestation of these effects can be classified according to the purpose of use in the composition, and the following can be exemplified. pH
Regulators, gel bases, vehicles, stabilizers, liquid carriers, solubilizers, surfactants, lubricants, sweeteners, buffers, absorption enhancers, flavoring agents, flavoring agents, flavoring agents, binders, Suspending agent, antioxidant, flavoring agent, fragrance, polymer thickener, solid carrier, bactericide, antioxidant, ultraviolet absorber, wetting agent, lubricant, pigment, hydrophilic base, water-soluble group Agent, refreshing agent, hydrophobic base,
Compatibilizer, thickener, extender, carrier, flavoring agent, colorant, additive, tonicity agent, ointment base, emulsifier, emulsion base, coating agent, excipient, flavoring agent, dispersant , Propellant, humectant, preservative, auxiliary agent, disintegrant, disintegration aid, disintegration inhibitor, swelling agent,
Antiseptic / bactericidal agent, antiseptic agent, soothing agent, oily base, solubilizing agent, solvent, fluidity promoter.
【0017】組成物中の構成成分において、使用目的に
よる各分類に含まれる個々の物質は、その化学構造、理
化学的性質、その由来起源もしくは、使用目的で分類す
ることも可能であり、次のようなものを例示することが
できる。これらの例示物質は、例示中の重複からも明ら
かなように、異なった組成物において、異なった使用目
的で用いることが可能な物質である。なお、本発明の組
成物中の構成成分における使用目的の重複は、例示中の
重複のみに限定されないことは勿論である。水。例え
ば、次のような内容の水を使用できる。ブドウ糖やその
他の補助薬を含む等張液(例えば、D−ソルビトール、
D−マンニトール、塩化ナトリウムなど)、ブドウ糖水
溶液、各種緩衝液、蒸溜水、生理食塩水、精製水、電解
質溶液、滅菌水、滅菌精製水、輸液剤。油脂類として
は、次のようなものを例示することができる。アーモン
ド油、アボガド油、ウイキョウ油、エゴマ油、オリーブ
油、オレンジラファー油、オレンジ油、カカオ脂、カミ
ツレ油、カロット油、キューカンバー油、ココナッツ
油、ゴマ油、サザンカ油、サフラワー油、タートル油、
ツバキ油、トウモロコシ油、ナタネ油、パーシック油、
パーム核油、パーム油、ヒマシ油、ホホバ油、ミンク
油、モクロウ、ヤシ油、ローズヒップ油、牛脂、月見草
油、硬化パーム油、硬化ヒマシ油、硬化ヤシ油、大豆
油、豚脂、馬油脂、綿実油、落花生油、卵黄油。In the constituent components of the composition, individual substances included in each classification according to the purpose of use can be classified according to their chemical structure, physicochemical properties, their origin of origin, or purpose of use. Such a thing can be illustrated. As is clear from the overlap in the examples, these exemplified substances are substances that can be used for different purposes in different compositions. In addition, it is needless to say that the overlapping of the purpose of use of the constituent components in the composition of the present invention is not limited to the overlapping in the examples. water. For example, water having the following contents can be used. Isotonic solutions containing glucose and other adjuvants (eg D-sorbitol,
D-mannitol, sodium chloride, etc., glucose aqueous solution, various buffer solutions, distilled water, physiological saline, purified water, electrolyte solution, sterilized water, sterilized purified water, infusion solution. Examples of fats and oils include the following. Almond oil, avocado oil, fennel oil, perilla oil, olive oil, orange laffer oil, orange oil, cacao butter, chamomile oil, carrot oil, cucumber oil, coconut oil, sesame oil, southern oil, safflower oil, turtle oil,
Camellia oil, corn oil, rapeseed oil, persic oil,
Palm kernel oil, palm oil, castor oil, jojoba oil, mink oil, mrow, coconut oil, rosehip oil, beef tallow, evening primrose oil, hydrogenated palm oil, hydrogenated castor oil, hydrogenated coconut oil, soybean oil, pork fat, horse oil and fat , Cottonseed oil, peanut oil, egg yolk oil.
【0018】ロウ類としては、次のようなものを例示す
ることができる。カルナバロウ、カンデリラロウ、コレ
ステロール、シリコン、スクワラン、セラックロウ、セ
レシン、パラフィン、パラフィンロウ、プラスチベー
ス、マイクロクリスタリンワックス、ミツロウ、モクロ
ウ、モンタンロウ、ラノリン、ワセリン、ワックス、液
状パラフィン、液状ラノリン、還元ラノリン、鯨ロウ、
固形パラフィン、硬質ラノリン、高級炭化水素、白色ワ
セリン、流動パラフィン。Examples of waxes include the following. Carnauba wax, candelilla wax, cholesterol, silicone, squalane, shellac wax, ceresin, paraffin, paraffin wax, plastibase, microcrystalline wax, beeswax, mrow, montan wax, lanolin, vaseline, wax, liquid paraffin, liquid lanolin, reduced lanolin, whale wax,
Solid paraffin, hard lanolin, higher hydrocarbons, white petrolatum, liquid paraffin.
【0019】鉱物油としては、次のようなものを例示す
ることができる。オゾケライド、セレシン、パラフィ
ン、プリスタン、ポリエチレン末、マイクロクリスタリ
ンワックス、ワセリン、流動パラフィン。脂肪酸類とし
ては、次のようなものを例示することができる。12-
ヒドロキシステアリン酸、2−エチルブタン酸、2−エ
チルヘキサン酸、2−メチルペンタン酸、イソノナン
酸、イソペンタン酸、ウンデシレン酸、オレイン酸、カ
プロン酸、ステアリン酸、トール油、パルミチン酸、パ
ルミトレイン酸、ベヘニン酸、ベヘン酸、ミリスチン
酸、ラウリン酸、ラノリン脂肪酸、リノール酸、リノレ
ン酸(α−リノレン酸、γ−リノレン酸)。As the mineral oil, the following can be exemplified. Ozokeride, ceresin, paraffin, pristane, polyethylene powder, microcrystalline wax, petrolatum, liquid paraffin. Examples of fatty acids include the following. 12-
Hydroxystearic acid, 2-ethylbutanoic acid, 2-ethylhexanoic acid, 2-methylpentanoic acid, isononanoic acid, isopentanoic acid, undecylenic acid, oleic acid, caproic acid, stearic acid, tall oil, palmitic acid, palmitoleic acid, behenic acid. , Behenic acid, myristic acid, lauric acid, lanolin fatty acid, linoleic acid, linolenic acid (α-linolenic acid, γ-linolenic acid).
【0020】アルコール類としては、次のようなものを
例示することができる。2−オクチルドデカノール、2
−ヘキシルデカノール、イソステアリルアルコール、イ
ソプロパノール、エタノール、オレイルアルコール、コ
レステロール、ステアリルアルコール、セタノール、セ
チルアルコール、フィトステロール、メタノール、ラウ
リルアルコール、ラノリンアルコール。多価アルコール
類としては、次のようなものを例示することができる。
1,3−ブチレングリコール、アラビノース、イソマル
トオリゴ糖類、イノシトール、エチレングリコール、エ
チレングリコールモノエチルエーテル、エチレングリコ
ールモノブチルエーテル、ガラクトース、キシリトー
ル、キシロース、キシロオリゴ糖類、グリセリン、コー
ンシロップ、シクロデキストリン(α−シクロデキスト
リン、β−シクロデキストリン、γ−シクロデキストリ
ン)、ショ糖、ジエチレングリコール、ジエチレングリ
コールモノエチルエーテル、ジエチレングリコールモノ
メチルエーテル、ジプロピレングリコール、ステビオサ
イド、セロビオース、ソルビトール、デキストリン類、
デンプン、トリエチレングリコール、トレハロース
(α,α−トレハロース)、バチルアルコール、パラチ
ノース、フルクトオリゴ糖類、ブドウ糖、プロピレング
リコール、ペンタエリトリトール、ポリエチレングリコ
ール、ポリビニルアルコール、ポリプロピレングリコー
ル、マルトース、マンニトール、マンノース、ラフィノ
ース、ルブソサイド、果糖、乳糖。Examples of alcohols include the following. 2-octyldodecanol, 2
Hexyldecanol, isostearyl alcohol, isopropanol, ethanol, oleyl alcohol, cholesterol, stearyl alcohol, cetanol, cetyl alcohol, phytosterols, methanol, lauryl alcohol, lanolin alcohol. Examples of the polyhydric alcohols include the following.
1,3-butylene glycol, arabinose, isomaltooligosaccharide, inositol, ethylene glycol, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, galactose, xylitol, xylose, xylooligosaccharide, glycerin, corn syrup, cyclodextrin (α-cyclodextrin) , Β-cyclodextrin, γ-cyclodextrin), sucrose, diethylene glycol, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether, dipropylene glycol, stevioside, cellobiose, sorbitol, dextrins,
Starch, triethylene glycol, trehalose (α, α-trehalose), batyl alcohol, palatinose, fructooligosaccharides, glucose, propylene glycol, pentaerythritol, polyethylene glycol, polyvinyl alcohol, polypropylene glycol, maltose, mannitol, mannose, raffinose, rubusoside, Fructose, lactose.
【0021】エステル類としては、次のようなものを例
示することができる。アジピン酸ジイソプロピル、オレ
イン酸エチル、オレイン酸オレイル、オレイン酸デシ
ル、カプロン酸エチル、グリセリンモノステアレート
(ステアリン酸モノグリセリド)、ジオレイン酸プロピ
レングリコール、ジメチルオクタン酸ヘキシルデシル、
ステアリン酸ブチル、セバシン酸ジエチル、ソルビタン
セスキオレート、ソルビタントリオレート、ソルビタン
モノオレート、ソルビタンモノステアレート、パルミチ
ン酸イソプロピル、フタル酸ジエチル、フタル酸ジブチ
ル、ポリオキシエチレンソルビタンモノオレエート、ポ
リオキシエチレンソルビタンモノステアレート、ポリオ
キシエチレン硬化ヒマシ油、ミリスチン酸イソプロピ
ル、ミリスチン酸オクチルドデシル、ミリスチン酸ミリ
スチル、モノオレイルポリオキシエチレンソルビタン、
モノステアリン酸エチレングリコール、モノステアリン
酸プロピレングリコール、ラウリン酸ヘキシル、酢酸ラ
ノリン、乳酸セチル、乳酸ミリスチル。金属セッケンと
しては、次のようなものを例示することができる。ウン
デシレン酸亜鉛、ステアリン酸アルミニウム、ステアリ
ン酸カルシウム、ステアリン酸マグネシウム、ステアリ
ン酸亜鉛、パルミチン酸亜鉛、ミリスチン酸マグネシウ
ム、ラウリン酸亜鉛。Examples of the esters include the following. Diisopropyl adipate, ethyl oleate, oleyl oleate, decyl oleate, ethyl caproate, glycerin monostearate (monoglyceride stearate), propylene glycol dioleate, hexyldecyl dimethyloctanoate,
Butyl stearate, diethyl sebacate, sorbitan sesquioleate, sorbitan trioleate, sorbitan monooleate, sorbitan monostearate, isopropyl palmitate, diethyl phthalate, dibutyl phthalate, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan monooleate Stearate, polyoxyethylene hydrogenated castor oil, isopropyl myristate, octyldodecyl myristate, myristyl myristate, monooleyl polyoxyethylene sorbitan,
Ethylene glycol monostearate, propylene glycol monostearate, hexyl laurate, lanolin acetate, cetyl lactate, myristyl lactate. The following can be illustrated as a metal soap. Zinc undecylenate, aluminum stearate, calcium stearate, magnesium stearate, zinc stearate, zinc palmitate, magnesium myristate, zinc laurate.
【0022】ガム質及び水溶性高分子化合物としては、
次のようなものを例示することができる。アイルランド
苔、アラビアガム、アルギン酸プロピレングリコールエ
ステル、アルギン酸及びその塩(アルギン酸アンモニウ
ム、アルギン酸カリウム、アルギン酸ナトリウム)、ア
ルゲコロイド(カッソウエキス)、アルブミン、エチル
セルロース、カゼイン、カラギーナン、カラヤガム、カ
ルボキシアルキルキチン又はキトサン、カルボキシエチ
ルセルロース、カルボキシエチルセルロースナトリウ
ム、カルボキシビニルポリマー(カーボポール)、カル
ボキシメチルキチンまたはその塩、カルボキシメチルセ
ルロース、カルボキシメチルセルロースカルシウム、カ
ルボキシメチルセルロースナトリウム、カルボキシメチ
ルデンプン、カンテン、ガラクタン、キサンタンガム、
キチンサルフェートまたはその塩、キトサンまたはその
塩、キャロブゴム、クインスシードガム、グアーガム、
グアヤク脂、グリコールキチン、グリセロゼラチン、コ
ーンスターチ、コラーゲン、コンドロイチン硫酸及びそ
の塩(コンドロイチン硫酸ナトリウム等)、サクシノグ
ルカン、ザンコート、ザンフロー、ジイソプロピルアミ
ンおよびトリエチルアミンのような有機アミンで予め中
和したカルボキシビニルポリマー、セラック、セルロー
ス硫酸ナトリウム、ゼラチン、タマリンドガム、タラガ
ム、ダンマルゴム、デキストリン、デルマタン硫酸及び
その塩(デルマタン硫酸ナトリウム等)、デンプン、ト
ラガカントガム、ニトロセルロース、ヒアルロン酸及び
その塩(ヒアルロン酸ナトリウム等)、ヒドロキシアル
キルキチン又はキトサン、ヒドロキシエチルセルロー
ス、ヒドロキシプロピルセルロース、ヒドロキシプロピ
ルデンプン、ヒドロキシプロピルメチルセルロース、ビ
ーガム、プルラン、ヘパラン硫酸及びその塩(ヘパラン
硫酸ナトリウム等)、ヘパリン、ベンゾインゴム、ペク
チン、ポリアクリル酸塩(例えば、ポリアクリル酸ナト
リウム)、ポリアルキレンオキサイド又はその架橋重合
物、ポリエチレンイミン、ポリエチレンオキサイド、ポ
リエチレングリコール、ポリエチレングリコール脂肪酸
エステル、ポリオキシエチレン−ポリオキシプロピレン
ブロック共重合体(例えば、プルロニック等)、ポリオ
キシエチレンアルキルエーテル、ポリオキシエチレンア
ルキルフェニルエーテル、ポリオキシエチレンイソステ
アリルエーテル、ポリオキシエチレンオキシプロピレン
アルキルエーテル、ポリオキシエチレンオキシプロピレ
ン共重合体、ポリオキシエチレンセチルエーテル、ポリ
オキシエチレンソルビタン脂肪酸エステル、ポリオキシ
エチレン硬化ヒマシ油、ポリビニルアルコール、ポリビ
ニルエーテル、ポリビニルピロリドン、ポリビニルメタ
アクリレート、ポリビニルメチルエーテル、ポリプロピ
レンオキサイド、マクロゴール、メチルセルロース、メ
チルヒドロキシプロピルセルロース、メチルヒドロキシ
プロピルデンプン、ラミナラン、リン酸化キチン又はキ
トサン、ローストビーンガム、結晶セルロース、低置換
ヒドロキシプロピルセルロース、低分子キトサン。The gum and water-soluble polymer compounds include
The following can be illustrated. Irish moss, gum arabic, propylene glycol alginate, alginic acid and its salts (ammonium alginate, potassium alginate, sodium alginate), algae colloid (cassius extract), albumin, ethyl cellulose, casein, carrageenan, karaya gum, carboxyalkyl chitin or chitosan, carboxyethyl cellulose. , Sodium carboxyethyl cellulose, carboxyvinyl polymer (Carbopol), carboxymethyl chitin or a salt thereof, carboxymethyl cellulose, carboxymethyl cellulose calcium, sodium carboxymethyl cellulose, carboxymethyl starch, agar, galactan, xanthan gum,
Chitin sulfate or its salt, chitosan or its salt, carob gum, quince seed gum, guar gum,
Guayak butter, glycol chitin, glycerogelatin, corn starch, collagen, chondroitin sulfate and its salts (sodium chondroitin sulfate, etc.), succinoglucan, zancoat, zanflo, carboxyvinyl polymer pre-neutralized with organic amines such as diisopropylamine and triethylamine. , Shellac, sodium cellulose sulfate, gelatin, tamarind gum, tara gum, dammar gum, dextrin, dermatan sulfate and its salt (sodium dermatan sulfate), starch, tragacanth gum, nitrocellulose, hyaluronic acid and its salt (sodium hyaluronate), hydroxy Alkyl chitin or chitosan, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl starch, hydro Cypropylmethyl cellulose, veegum, pullulan, heparan sulfate and its salts (sodium heparan sulfate, etc.), heparin, benzoin gum, pectin, polyacrylic acid salt (for example, sodium polyacrylate), polyalkylene oxide or its cross-linked polymer, polyethylene Imines, polyethylene oxides, polyethylene glycols, polyethylene glycol fatty acid esters, polyoxyethylene-polyoxypropylene block copolymers (for example, pluronics, etc.), polyoxyethylene alkyl ethers, polyoxyethylene alkyl phenyl ethers, polyoxyethylene isostearyl ethers. , Polyoxyethylene oxypropylene alkyl ether, polyoxyethylene oxypropylene copolymer, polyoxyethylene cet Ether, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene hydrogenated castor oil, polyvinyl alcohol, polyvinyl ether, polyvinylpyrrolidone, polyvinyl methacrylate, polyvinyl methyl ether, polypropylene oxide, macrogol, methyl cellulose, methyl hydroxypropyl cellulose, methyl hydroxypropyl starch , Laminaran, phosphorylated chitin or chitosan, roast bean gum, crystalline cellulose, low-substituted hydroxypropyl cellulose, low-molecular chitosan.
【0023】ビタミンA群類としては、次のようなもの
を例示することができる。カロチン(プロビタミン
A)、デヒドロレチノール(ビタミンA2)、レチノー
ル(ビタミンA1)。ビタミンB群類としては、次のよ
うなものを例示することができる。イノシトール類、コ
リン、シアノコバラミン(ビタミンB12)、チアミン塩
酸塩(ビタミンB1塩酸塩)、チアミン硫酸塩(ビタミ
ンB1硫酸塩)、ニコチン酸アミド、ニコチン酸類、パ
ントテン酸カルシウム、パントテン酸類、ビオチン類、
ピリドキシン(ビタミンB6)、リボフラビン(ビタミ
ンB2)、葉酸類。ビタミンC群類としては、次のよう
なものを例示することができる。アスコルビン酸及びそ
の誘導体。ビタミンD群類としては、次のようなものを
例示することができる。エルゴカルシフェロール(ビタ
ミンD2)、エルゴステリン(プロビタミンD2)、コ
レカルシフェロール(ビタミンD3)、7−デヒドロ−
コレステリン(プロビタミンD3)。ビタミンE群類と
しては、次のようなものを例示することができる。トコ
フェロール及びその誘導体。ビタミンK群類としては、
次のようなものを例示することができる。フィロキノン
(ビタミンK1)、フアルノキノン(ビタミンK2)、メ
ナジオール(ビタミンK4)、メナジオン(ビタミンK
3)。その他のビタミン類や、ビタミン類含有物に、補
酵素Q、ロイヤルゼリーなどもある。As the vitamin A group, the following can be exemplified. Carotene (provitamin A), dehydroretinol (vitamin A2), retinol (vitamin A1). The following can be illustrated as a vitamin B group. Inositols, choline, cyanocobalamin (vitamin B12), thiamine hydrochloride (vitamin B1 hydrochloride), thiamine sulfate (vitamin B1 sulfate), nicotinic acid amide, nicotinic acids, calcium pantothenate, pantothenic acids, biotins,
Pyridoxine (vitamin B6), riboflavin (vitamin B2), folic acid. The following can be illustrated as a vitamin C group. Ascorbic acid and its derivatives. The following can be illustrated as a vitamin D group. Ergocalciferol (vitamin D2), ergosterin (provitamin D2), cholecalciferol (vitamin D3), 7-dehydro-
Cholesterin (Provitamin D3). The following can be illustrated as a vitamin E group. Tocopherol and its derivatives. As vitamin K group,
The following can be illustrated. Phylloquinone (vitamin K1), Fuarnoquinone (vitamin K2), Menadiol (vitamin K4), Menadione (vitamin K)
3). Other vitamins and vitamin-containing substances include coenzyme Q and royal jelly.
【0024】アミノ酸としては、次のようなものを例示
することができる。アスパラギン、アスパラギン酸、ア
ラニン、アルギニン、イソロイシン、オキシプロリン、
オキシリジン、オルニチン、グリシン、グルタミン、グ
ルタミン酸、シスチン、システイン、セリン、チロシ
ン、トリプトファン、トレオニン、バリン、ヒスチジ
ン、フェニルアラニン、プロリン、メチオニン、リジ
ン、ロイシンなどや、それらの硫酸塩、リン酸塩、硝酸
塩、クエン酸塩、ナトリウム塩、あるいはピロリドンカ
ルボン酸ようなアミノ酸誘導体など。Examples of amino acids include the following. Asparagine, aspartic acid, alanine, arginine, isoleucine, oxyproline,
Oxylysine, ornithine, glycine, glutamine, glutamic acid, cystine, cysteine, serine, tyrosine, tryptophan, threonine, valine, histidine, phenylalanine, proline, methionine, lysine, leucine, and their sulfates, phosphates, nitrates, citrates, etc. Acid salts, sodium salts, or amino acid derivatives such as pyrrolidonecarboxylic acid.
【0025】植物、生薬としては、次のようなものを例
示することができる。アシタバ、アズキ(赤小豆)、ア
セロラ、アセンヤク(阿仙薬)、アボカド、アマチャ
(甘茶)、アマチャヅル、アルテア、アルニカ、アロ
エ、アロエベラ、アンズ(杏仁)、イチョウ(銀杏葉、
銀杏)、イトヒメハギ(遠志)、イラクサ、イワハゼ
(赤物)、ウイキョウ(茴香)、ウコン(鬱金)、ウス
バサイシン(細辛)、ウツボグサ(夏枯草)、ウドまた
はシシウド(羌活、独活)、ウメ(烏梅)、ウラジロガ
シ、ウワウルシ、ウンシュウミカン(陳皮)、エビスグ
サ(決明子)、エンジュ(槐花)、オウギ(黄耆)、オ
ウレン(黄連)、オオバコ(車前子、車前草)、オオム
ギ(麦芽)、オタネニンジン(人参)、オトギリソウ
(弟切草)、オドリコソウ、オランダガラシ、オレン
ジ、カキ(柿蒂)、カノコソウ(吉草根)、カミツレ、
カワラヨモギ(茵チン蒿)、カンゾウ(甘草)、ガジュ
ツ(莪朮)、キイチゴ、キウイ果実、キカラスウリ(瓜
呂根)、キキョウ(桔梗)、キク(菊花)、キササゲ
(梓実)、キハダ(黄柏)、キュウリ、クコ(地骨皮、
枸杞子、枸杞葉)、クスノキ、クズ(葛根)、クチナシ
(山梔子)、クマザサ、クララ(苦参)、クワ(桑白
皮、桑葉)、グレープフルーツ果実、ケイガイ(ケイガ
イ)、ゲンチアナ、ゲンノショウコ(老鸛草)、コウチ
ャ(紅茶)、コガネバナ(オウゴン)、コムギ、ゴシュ
ユ(呉茱萸)、ゴバイシ(五倍子)、ゴボウ、サフラ
ン、サボンソウ、サルビア、サンザシ(山ザ子)、サン
シチニンジン(三七人参)、サンショウ(山椒)、シイ
タケ、シクンシ(使君子)、シソ(紫蘇葉、紫蘇子)、
シモツケソウ、シャクヤク(芍薬)、ショウガ(生
姜)、ショウブ(菖蒲)、シラカバ、ジオウ(地黄)、
ジャノヒゲ(麦門冬)、スイカズラ(金銀花、忍冬)、
ステビア、セイヨウキヅタ、セイヨウニワトコ、セイヨ
ウノコギリソウ、センキュウ(川キュウ)、センブリ
(当薬)、ゼニアオイ、タチジャコウソウ、タチバナ
(橘皮)、タラノキ、ダイズ、ダイダイ(橙皮)、チク
セツニンジン(竹節人参)、チョウジ(丁子)、チョウ
センゴミシ(五味子)、ツバキ、ツボクサ、ツルドクダ
ミ(何首烏)、トウガラシ(番椒)、トウガラシ、トウ
キ(当帰)、トウキンセンカ、トウネズミモチ(女貞
子)、トウモロコシ(南蛮毛)、トチュウ(杜仲、杜仲
葉)、トマト、ドクダミ(十薬)、ナツメ(大棗)、ナ
ルコユリ、ナンテン(南天実)、ニッケイ(桂皮)、ニ
ワトコ(接骨木)、ニンニク(大サン)、ノイバラ(営
実)、ハクセン(白蘚皮)、ハシリドコロ(ロート
根)、ハッカ(薄荷)、ハトムギ(ハトムギ、ヨクイニ
ン)、ハナスゲ(知母)、ハマメリス、バラ、パセリ、
ヒオウギ(射干)、ヒキオコシ(延命草)、ヒナタイノ
コズチ(牛膝)、ビワ葉(枇杷葉)、ビンロウジュ(檳
ロウ子)、フユムシナツクサタケ(冬虫夏草)、ブドウ
またはその葉、ヘチマ、ベニバナ(紅花)、ホオズキ
(登呂根)、ホオノキ(厚朴)、ホップ、ボケ(木
瓜)、ボタン(牡丹皮)、ボダイジュ、マイカイ(マイ
瑰花)、マツホド(茯リョウ)、マルバアサガオ又はア
サガオ(ケン牛子)、マロニエ、マンネンタケ(霊
芝)、マンネンロウ、ミカン属植物果実(枳実)、ミシ
マサイコ(柴胡)、ムクロジ、ムラサキ(紫根)、メハ
ジキ(益母草)、メリッサ、メリロート、モウコヨモ
ギ、モモ(桃仁、桃葉)、モヤシ、ヤグルマギク、ヤマ
ザクラ(桜皮)、ヤマモモ(楊梅皮)、ヤマヨモギ、ユ
キノシタ(虎耳草)、ヨモギ(ガイ葉)、ラカンカ、ラ
ベンダー、リョクチャ(緑茶)、リンゴ果実、レモン果
実、レンギョウ(連翹)、レンゲソウ、ワレモコウ(地
楡)、松葉、米、米ぬか。上記の植物及び生薬は、本発
明の組成物に、そのままもしくは、抽出物の形態で利用
できる。抽出物は、水、有機溶媒(1,3−ブチレング
リコール、アセトン、エーテル、エタノール、プロピレ
ングリコール、メチルエチルケトン、酢酸エチルなど)
の1種又は2種以上の混合溶媒で抽出して調製する。Examples of plants and herbal medicines are as follows. Ashitaba, Azuki (red azuki bean), Acerola, Asenyak (Asenyaku), Avocado, Amacha (sweet tea), Amateur Crane, Althea, Arnica, Aloe, Aloe Vera, Apricot (Apricot kernel), Ginkgo (Ginkgo leaf,
Ginkgo), Itohimehagi (distinct), nettle, sardine goby (red), fennel (incense), turmeric (light gold), usubasaishin (spicy), hemlock (summer hay), udo or shishudo (spoiler, independent activity), plum ( (Ume), Vladimir, Ural, Unshiu mandarin (Chen skin), Ebisugusa (Keimeiko), Enju (Sophora), Ougi (Yellow 耆), Oo Ren (Huang Lian), Psyllium (Cornaceae, Carp grass), Barley (malt), Panax ginseng (carrot), Hypericum (younger brother cut grass), Odorikosou, Dutch pepper, orange, oyster (persimmon), valerian (Yoshikusa), chamomile,
Kawamura Mugwort (Chinese linseed), Licorice (liquorice), Banjutsu (lichen), Raspberry, Kiwi fruit, Chikarasuuri (melon root), Kyoukyo (Kikyo), Chrysanthemum (Chrysanthemum), Kisage (Apricot), Yellowfin (Kashiwa) , Cucumber, wolfberry
Marlin, Marcus leaf, Camphor tree, Kudzu (Kudzu root), Gardenia (Yamasuko), Kumazasa, Clara (Ginseng), Mulberry (Mulberry bark, Mulberry leaf), Grapefruit fruit, Kaigai (Keikai), Gentiana, Gensho (Old) Birds), Koucha (black tea), Scutellaria baicalensis (Ouchon), Wheat, Goshuyu (Kurei), Gobaishi (quintile), burdock, saffron, saponsou, salvia, hawthorn (yamazako), Sanshi carrot (37 ginseng) , Sansho (Japanese pepper), Shiitake mushroom, Shikunshi (Kimiko), Shiso (Shiso leaf, Shiso),
Spirea, peony (peony), ginger (ginger), ginger (iris), birch, dio (ground yellow),
Janow mustache (Bakumon winter), Honeysuckle (gold and silver flowers, Shinobi winter),
Stevia, Ivy, Sambucus nigra, St. John's wort, Sengyu (river cucumber), senburi (our medicine), mallow, tachijakusa, tachibana (tachibana peel), arachis, soybean, red sea bream (orange peel), ginseng carrot ), Clove (chopsticks), ginseng (schisandra), camellia, centella asiatica, tsurudokudami (what-headed crow), capsicum (pepper), capsicum, capsicum (toki), capsicum, corn rat (madako), corn (nanbari fur) ), Eucommia vulgaris (Tochu, Tochu leaf), Tomato, Dokudami (10 medicines), Jujube (Oju), Narukoyuri, Nanten (Namitenmi), Nikkei (cinnamon skin), Elderflower (bone grafting), garlic (Large sun), Neubara (Fruit), Hakusen (white moss bark), Hashiridokoro (roth root), peppermint (light load), pigeon Formic (pearl barley, Coix), Anemarrhenae asphodeloides (knowledge mother), Hamamelis, rose, parsley,
Hyougi (dried dry), Hikiokoshi (prolonged life grass), Hinako no Kochi (cow knee), loquat leaf (Biwaki leaf), Areca (Columba coccinata), Fuyumusinatsukutake (winter caterpillar), grape or its leaf, loofah, safflower (safflower) ), Physalis (Torone), honoki (Koboku), hops, bokeh (wood melon), buttons (peony skin), bodaiju, maikai (mai agate flower), matsuhodo (bottle lily), malva morning glory or morning glory (ken beef) , Horse chestnut, ganoderma lucidum, ganoderma lucidum, citrus fruit (clover), mishimasiko (shibaiko), mukuroji, murasaki (purple root), swordfish (beneficial herb), melissa, merlot, moco wormwood, peach (peach root, peach leaf), Bean sprouts, cornflowers, cherry trees (cherry bark), bayberry (Yangmei bark), bayberry, Yukinoshita (tiger ear grass), mugwort ( Lee leaves), Swingle, lavender, green tea (green tea), apple fruit, lemon fruit, forsythia (Forsythia), Rengesou, burnet (Chinire), pine needles, rice, rice bran. The above plants and herbal medicines can be used in the composition of the present invention as they are or in the form of extracts. The extract is water, an organic solvent (1,3-butylene glycol, acetone, ether, ethanol, propylene glycol, methyl ethyl ketone, ethyl acetate, etc.)
It is prepared by extraction with one or two or more mixed solvents.
【0026】動物由来のものとしては、次のようなもの
を例示することができる。抽出方法は、植物及び生薬の
場合に準じた方法を用いることができる。エラスチン、
エラスチン加水分解物、コラーゲン加水分解物、シルク
蛋白、シルク蛋白分解物、牛・人の胎盤抽出物、牛血球
蛋白分解物、家畜の器官や臓器の抽出物若しくはその分
解物(鶏トサカ、豚・牛の胃、十二指腸、或いは腸)、
水溶性エラスチン誘導体、水溶性コラーゲン、水溶性コ
ラーゲン誘導体。微生物培養物由来のものとしては、次
のようなものを例示することができる。セレン含有酵母
エキス、ユーグレナ抽出物、酵母エキス、脱脂粉乳の乳
酸発酵物、米醗酵エキス。Examples of animal-derived substances include the following. As the extraction method, a method similar to that for plants and crude drugs can be used. Elastin,
Elastin hydrolyzate, collagen hydrolyzate, silk protein, silk protein hydrolyzate, bovine / human placenta extract, bovine blood cell protein hydrolyzate, livestock organ or organ extract or its hydrolyzate (chicken gooseberry, pig)・ Stomach of the cow, duodenum, or intestine),
Water-soluble elastin derivative, water-soluble collagen, water-soluble collagen derivative. Examples of those derived from a microbial culture include the following. Selenium-containing yeast extract, euglena extract, yeast extract, lactic acid fermentation product of skim milk powder, rice fermentation extract.
【0027】香料としては、次のようなものを例示する
ことができる。アンバーグリス、カストリウム、シベッ
ト、ジャコウ、などの天然動物性香料。アニス精油、ア
ンゲリカ精油、イランイラン精油、イリス精油、ウイキ
ョウ精油、オレンジ精油、カナンガ精油、カラウェー精
油、カルダモン精油、クミン精油、グアヤクウッド精
油、ケイ皮精油、ゲラニウム精油、コパイババルサム精
油、コリアンデル精油、シソ精油、シダーウッド精油、
シトロネラ精油、シンナモン精油、ジャスミン精油、ジ
ンジャーグラス精油、スペアミント精油、チュベローズ
精油、トルーバルサム精油、バチュリー精油、バラ精
油、バジル精油、パルマローザ精油、ヒバ精油、プチグ
レン精油、ベイ精油、ベチバ精油、ベルガモット精油、
ペルーバルサム精油、ボアドローズ精油、マンダリン精
油、ユーカリ精油、ライム精油、ラベンダー精油、リナ
ロエ精油、レモングラス精油、レモン精油、ローズマリ
ー精油、黒文字精油、杉精油、西洋ハッカ精油、大茴香
精油、丁字精油、冬緑精油、白檀精油、芳樟精油、和種
ハッカ精油、桧精油、橙花精油などの植物性香料、その
他合成香料。Examples of the fragrance include the following. Natural animal flavors such as Ambergris, Castorium, Civet, Musk. Anise essential oil, angelica essential oil, ylang-ylang essential oil, iris essential oil, fennel essential oil, orange essential oil, cananga essential oil, caraway essential oil, cardamom essential oil, cumin essential oil, guaiac wood essential oil, cinnamon essential oil, geranium essential oil, copaiba balsam essential oil, coriandel essential oil, perilla Essential oil, cedarwood essential oil,
Citronella essential oil, cinnamon essential oil, jasmine essential oil, ginger grass essential oil, spearmint essential oil, tuberose essential oil, true balsam essential oil, butchery essential oil, rose essential oil, basil essential oil, palmarosa essential oil, hiba essential oil, petitgrain essential oil, bay essential oil, vetiver essential oil, bergamot essential oil,
Peruvian balsam essential oil, boad rose essential oil, mandarin essential oil, eucalyptus essential oil, lime essential oil, lavender essential oil, linaloe essential oil, lemongrass essential oil, lemon essential oil, rosemary essential oil, black character essential oil, cedar essential oil, western mint essential oil, large scented essential oil, taiji essential oil, Vegetable-based fragrances such as winter green essential oil, sandalwood essential oil, scented essential oil, Japanese peppermint essential oil, cypress essential oil, orange essential oil, and other synthetic fragrances.
【0028】カルボン酸類としては、次のようなものを
例示することができる。コハク酸、クエン酸、グリコー
ル酸、リンゴ酸、酒石酸、乳酸。pH調整剤としては、
次のようなものを例示することができる。L−アスパラ
ギン酸、L−グルタミン酸、アルギニン、クエン酸、ジ
イソプロパノールアミン、リン酸緩衝液、塩酸、酒石
酸、酢酸、水酸化カリウム、水酸化ナトリウム、乳酸。
緩衝剤としては、次のようなものを例示することができ
る。アミノ酢酸、クエン酸、クエン酸ナトリウム、ヒン
ド−ゴーヤン(Hind−Goyan)緩衝液[リン酸
二水素ナトリウム、リン酸水素二ナトリウム、塩化ナト
リウムから成る]、ブリットン−ロビンソン(Brit
ton−Robinson)緩衝液[リン酸、酢酸、ホ
ウ酸、水酸化ナトリウムから成る]、ホウ砂、ホウ酸、
リン酸、リン酸のアルカリ金属塩(リン酸水素二カリウ
ム、リン酸水素二ナトリウム、リン酸二水素カリウム、
リン酸二水素ナトリウム)、リン酸塩緩衝液、酢酸、酢
酸ナトリウム、酢酸ナトリウム緩衝液、炭酸ナトリウ
ム、炭酸水素ナトリウム。Examples of carboxylic acids include the following. Succinic acid, citric acid, glycolic acid, malic acid, tartaric acid, lactic acid. As a pH adjuster,
The following can be illustrated. L-aspartic acid, L-glutamic acid, arginine, citric acid, diisopropanolamine, phosphate buffer, hydrochloric acid, tartaric acid, acetic acid, potassium hydroxide, sodium hydroxide, lactic acid.
The following can be illustrated as a buffering agent. Aminoacetic acid, citric acid, sodium citrate, Hind-Goyan buffer [consisting of sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium chloride], Britton-Robinson (Brit)
ton-Robinson) buffer [consisting of phosphoric acid, acetic acid, boric acid, and sodium hydroxide], borax, boric acid,
Phosphoric acid, alkali metal salts of phosphoric acid (dipotassium hydrogen phosphate, disodium hydrogen phosphate, potassium dihydrogen phosphate,
Sodium dihydrogen phosphate), phosphate buffer, acetic acid, sodium acetate, sodium acetate buffer, sodium carbonate, sodium hydrogen carbonate.
【0029】アニオン界面活性剤としては、次のような
ものを例示することができる。1,2−ビス[(2−エ
チルヘキシル)オキシカルボニル]エタンスルホン酸ナ
トリウム塩(ジアルキルスルホコハク酸エステル塩の一
種);2−[(炭素数2nアルキル)(OCH2CH2 )m ]酢
酸 ナトリウム塩もしくは、カリウム塩(炭素数のn
は、6 〜9 の整数。m は整数);(炭素数2nアルキル)
ベンゼンスルホン酸 ナトリウム塩(炭素数のn は、6
〜9 の整数);[4−エチル−1−(2−メチルプロピ
ル)オクチル]硫酸エステル ナトリウム塩;N−
[(炭素数(2n-1)アルキル)カルボニル]−N−メチル
−β−アラニンナトリウム塩(炭素数のn は、6 〜9 の
整数);N−[(炭素数(2n-1)アルキル)カルボニル]
−N−メチルグリシン ナトリウム塩(炭素数のn は、
6 〜9 の整数);N−[(炭素数(2n-1)アルキル)カル
ボニル]−N−メチルタウリン ナトリウム塩、カリウ
ム塩もしくは、トリエタノールアミン塩(炭素数のn
は、6 〜9の整数);N−[(炭素数(2n-1)アルキル)
カルボニル]グルタミン酸 ジナトリウム塩(炭素数の
n は、6 〜9 の整数);アルキルリン酸エステル塩
[(炭素数2nアルキル)O ]m P(O)(OM)t、(式中、n
は、6 〜9 の整数、m は、1 〜3 の整数、t は、0 〜2
の整数。M は、カリウム、ナトリウム等);α−オレフ
ィンスルホン酸ナトリウム塩、アルケン(C8〜C30 )モ
ノスルホン酸ナトリウム塩(R-CH=CH-(CH2)n-SO3Na)、
ヒドロキシアルカン(C8〜C24 )スルホン酸ナトリウム
塩(R-CH2-CH(OH)-(CH2)m-SO3Na )(式中、m 、n は、
各々整数);エデト酸塩;ラウリル硫酸エステル ナト
リウム塩;炭素数(2n-1)アルカンカルボン酸 ナトリウ
ム塩もしくは、カリウム塩(炭素数のn は、6 〜9 の整
数);Examples of the anionic surfactant include the following. 1,2-Bis [(2-ethylhexyl) oxycarbonyl] ethanesulfonic acid sodium salt (a kind of dialkylsulfosuccinic acid ester salt); 2-[(C2n alkyl) (OCH 2 CH 2 ) m] acetic acid sodium salt or , Potassium salt (n of carbon number
Is an integer from 6 to 9. m is an integer); (C2n alkyl)
Benzenesulfonic acid sodium salt (the carbon number n is 6
To an integer of 9); [4-ethyl-1- (2-methylpropyl) octyl] sulfate sodium salt; N-
[(Carbon number (2n-1) alkyl) carbonyl] -N-methyl-β-alanine sodium salt (n of carbon number is an integer of 6 to 9); N-[(carbon number (2n-1) alkyl) Carbonyl]
-N-methylglycine sodium salt (n of carbon number is
N-[(C (2n-1) alkyl) carbonyl] -N-methyltaurine sodium salt, potassium salt or triethanolamine salt (n of carbon number)
Is an integer of 6 to 9); N-[(carbon number (2n-1) alkyl)
Carbonyl] glutamic acid disodium salt (carbon number
n is an integer of 6 to 9); alkyl phosphate ester salt [(C2nalkyl) O] mP (O) (OM) t, (wherein n
Is an integer from 6 to 9, m is an integer from 1 to 3, t is 0 to 2
Integer. M is potassium, sodium, etc.); alpha-olefin sulfonate sodium salt, alkene (C 8 ~C 30) monosulfonic acid sodium salt (R-CH = CH- (CH 2) n-SO 3 Na),
Hydroxyalkane (C 8 ~C 24) sulfonic acid sodium salt (R-CH 2 -CH (OH ) - (CH 2) m-SO 3 Na) ( wherein, m, n are,
Edetate; lauryl sulfate sodium salt; carbon number (2n-1) alkanecarboxylic acid sodium salt or potassium salt (n of carbon number is an integer of 6 to 9);
【0030】カチオン界面活性剤としては、次のような
ものを例示することができる。1−(炭素数2nアルキ
ル)−1−(炭素数m アルキル)−2−(炭素数t アル
キル)−イミダゾリニウム塩化物もしくは、臭化物(炭
素数、n は、6 〜12の整数。m は、1 〜5 の整数。t
は、1 〜4 の整数);1−(炭素数2nアルキル)−2−
(炭素数t アルキル)−イミダゾリニウム塩化物もしく
は、臭化物(炭素数、n は、6 〜12の整数。t は、炭素
数1 〜4 の整数);塩化ベンザルコニウム([PhCH2N(CH
3)2(R)]+・X- )[式中、R は、炭素数2nアルキル(n
は、6 〜12の整数)、X は、塩素もしくは、臭素];塩
化ベンゼトニウム[[2-[2-[4-(1,1,3,3-テトラメチ
ルブチル)フェニルオキシ]エチルオキシ]エチル]
(フェニルメチル)](ジメチル)アンモニウム塩化
物;脂肪族4級アンモニウム塩([R1(R2)N(CH3)2]+・
X-)[式中、R1は、炭素数2nアルキル(n は、6 〜9 の
整数)。R2は、炭素数2nアルキル(n は、6 〜9 の整
数)もしくは、メチル。X は、塩素もしくは、臭素];
脂肪族アミン塩(RN(R1)R2 有機酸塩もしくは、無機酸
塩)[式中、R は、炭素数2nアルキル(n は、6 〜9 の
整数)。R1、R2は各々、水素もしくは、メチル];炭素
数2nアルキルピリジウム塩化物もしくは、臭化物(炭素
数のn は、6 〜9の整数)。Examples of the cationic surfactant include the following. 1- (C2n alkyl) -1- (carbon m alkyl) -2- (carbon t alkyl) -imidazolinium chloride or bromide (carbon number, n is an integer of 6 to 12. m is , An integer from 1 to 5. t
Is an integer of 1 to 4); 1- (C2n alkyl) -2-
(Ct alkyl) -imidazolinium chloride or bromide (carbon number, n is an integer of 6 to 12; t is an integer of 1 to 4); benzalkonium chloride ([PhCH 2 N ( CH
3) 2 (R)] + · X -) [ wherein, R has a carbon number of 2n alkyl (n
Is an integer of 6 to 12), X is chlorine or bromine]; benzethonium chloride [[2- [2- [4- (1,1,3,3-tetramethylbutyl) phenyloxy] ethyloxy] ethyl]
(Phenylmethyl)] (dimethyl) ammonium chloride; Aliphatic quaternary ammonium salt ([R 1 (R 2 ) N (CH 3 ) 2 ] +.
X -) [In the formula, R 1 is the number 2n alkyl (n carbon, of 6-9 integer). R 2 is alkyl having 2n carbon atoms (n is an integer of 6 to 9) or methyl. X is chlorine or bromine];
Aliphatic amine salt (RN (R 1 ) R 2 organic acid salt or inorganic acid salt) [In the formula, R 2 is an alkyl having 2n carbon atoms (n is an integer of 6 to 9). R 1 and R 2 are each hydrogen or methyl]; carbon number 2n alkylpyridinium chloride or bromide (n of carbon number is an integer of 6 to 9).
【0031】両性界面活性剤としては、次のようなもの
を例示することができる。1−カルボキシメチル−1−
ヒドロキシエチル−2−(炭素数(2n-1)アルキル)イミ
ダゾリニウム 水酸化物 分子内塩(炭素数のn は、6
〜9 の整数);2−[(炭素数2nアルキル)アミノ]酢
酸(炭素数のn は、6 〜9 の整数);3−[(炭素数2n
アルキル)アミノ]プロピオン酸(炭素数のn は、6 〜
9 の整数);(炭素数2nアルキル)(カルボキシメチ
ル)ジメチルアンモニウム 水酸化物分子内塩(炭素数
のn は、6 〜9 の整数);(炭素数2nアルキル)[2−
(カルボキシ)エチル]ジメチルアンモニウム水酸化物
分子内塩(炭素数のn は、6 〜9 の整数);N−
[(炭素数(2n-1)アルキル)カルボニル]−N−(2−
ヒドロキシエチル)−N´−カルボキシメチルエチレン
ジアミン(炭素数のn は、6 〜9 の整数);N−[(炭
素数(2n-1)アルキル)カルボニル]−N´−カルボキシ
メチル−N´−(2−ヒドロキシエチル)エチレンジア
ミン(炭素数のn は、6 〜9 の整数);ラウリルスルホ
ベタイン;レシチン。Examples of the amphoteric surfactant include the following. 1-carboxymethyl-1-
Hydroxyethyl-2- (carbon number (2n-1) alkyl) imidazolinium hydroxide inner salt (n of carbon number is 6
~ 9 (integer of 9); 2-[(C2n alkyl) amino] acetic acid (n of carbon is an integer of 6 to 9); 3-[(Cn of 2n
Alkyl) amino] propionic acid (n of carbon number is 6 to
(Integer of 9); (2n alkyl of carbon) (carboxymethyl) dimethylammonium hydroxide inner salt (n of carbon is an integer of 6 to 9); (2n alkyl of carbon) [2-
(Carboxy) ethyl] dimethylammonium hydroxide inner salt (n of carbon number is an integer of 6 to 9); N-
[(C (2n-1) alkyl) carbonyl] -N- (2-
Hydroxyethyl) -N'-carboxymethylethylenediamine (n in carbon number is an integer of 6 to 9); N-[(carbon number (2n-1) alkyl) carbonyl] -N'-carboxymethyl-N '-( 2-hydroxyethyl) ethylenediamine (n in carbon number is an integer of 6 to 9); laurylsulfobetaine; lecithin.
【0032】非イオン界面活性剤としては、次のような
ものを例示することができる。イソオクタン酸セチル、
オレイン酸エチル、カプリル酸エチル、グリセリンモノ
ステアレート、グリセリン脂肪酸エステル、ショ糖脂肪
酸エステル、シリコーンオイル、シリコーン樹脂等のシ
リコーン誘導体、ジステアリン酸ジグリセリン、ソルビ
タンセスキオレート、ソルビタンモノオレート、ソルビ
タンモノステアレート、ソルビタン脂肪酸エステル、ポ
リエチレングリコール脂肪酸エステル、ポリオール変性
シリコーン、ポリオキシエチレン(50)硬化ヒマシ
油、ポリオキシエチレン−ポリオキシプロピレンブロッ
ク共重合体、ポリオキシエチレンアルキルエーテル、ポ
リオキシエチレンアルキルフェニルエーテル、ポリオキ
シエチレンオキシプロピレン共重合体、ポリオキシエチ
レングリセリン脂肪酸エステル、ポリオキシエチレンセ
チルエーテル、ポリオキシエチレンステロールエーテ
ル、ポリオキシエチレンソルビタンモノオレエート(例
えば、ポリソルベート80)、ポリオキシエチレンソル
ビタンモノステアレート、ポリオキシエチレンソルビタ
ン脂肪酸エステル、ポリオキシエチレンソルビトール脂
肪酸エステル、ポリオキシエチレンヒマシ油誘導体、ポ
リオキシエチレン硬化ヒマシ油、ポリオキシエチレン高
級アルコールエーテル、ポリオキシエチレン脂肪酸エス
テル、ポリグリセリンアルキルフェニルエーテル、ポリ
グリセリン脂肪酸エステル、ミリスチン酸イソプロピ
ル、モノオレイルポリオキシエチレンソルビタン、モノ
オレイン酸グリセリン、モノオレイン酸プロピレングリ
コール、モノカプリン酸ソルビタン、モノステアリン酸
グリセリン、モノラウリン酸デカグリセリル等のエステ
ル。含窒素型非イオン界面活性剤としては、次のような
ものを例示することができる。N−(2−ヒドロキシエ
チル)−(炭素数(2n-1)アルカン)カルボン酸アミド
(炭素数のn は、6 〜9 の整数);N,N−ビス(2−
ヒドロキシエチル)−(炭素数(2n-1)アルカン)カルボ
ン酸アミド(炭素数のn は、6 〜9 の整数);N,N−
ビス(ポリオキシエチル)−(炭素数(2n-1)アルカン)
カルボン酸アミド(炭素数のn は、6 〜9 の整数);
(炭素数2nアルキル)ジメチルアミンオキシド(炭素数
のn は、6 〜9 の整数)。Examples of the nonionic surfactant include the following. Cetyl isooctanoate,
Ethyl oleate, ethyl caprylate, glycerin monostearate, glycerin fatty acid ester, sucrose fatty acid ester, silicone oil, silicone derivatives such as silicone resin, diglyceryl distearate, sorbitan sesquioleate, sorbitan monostearate, sorbitan monostearate, Sorbitan fatty acid ester, polyethylene glycol fatty acid ester, polyol-modified silicone, polyoxyethylene (50) hydrogenated castor oil, polyoxyethylene-polyoxypropylene block copolymer, polyoxyethylene alkyl ether, polyoxyethylene alkylphenyl ether, polyoxy Ethyleneoxypropylene copolymer, polyoxyethylene glycerin fatty acid ester, polyoxyethylene cetyl ether, poly Xyethylene sterol ether, polyoxyethylene sorbitan monooleate (for example, polysorbate 80), polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbitol fatty acid ester, polyoxyethylene castor oil derivative, polyoxy Ethylene hydrogenated castor oil, polyoxyethylene higher alcohol ether, polyoxyethylene fatty acid ester, polyglycerin alkyl phenyl ether, polyglycerin fatty acid ester, isopropyl myristate, monooleyl polyoxyethylene sorbitan, glyceryl monooleate, propylene glycol monooleate , Sorbitan monocaprate, glyceryl monostearate, decaglyceryl monolaurate Ester and the like. The following can be illustrated as a nitrogen-containing nonionic surfactant. N- (2-hydroxyethyl)-(carbon number (2n-1) alkane) carboxylic acid amide (n of carbon number is an integer of 6 to 9); N, N-bis (2-
Hydroxyethyl)-(carbon number (2n-1) alkane) carboxylic acid amide (n of carbon number is an integer of 6 to 9); N, N-
Bis (polyoxyethyl)-(carbon number (2n-1) alkane)
Carboxylic amide (n of carbon number is an integer of 6 to 9);
(C2n alkyl) dimethylamine oxide (n of carbon is an integer of 6 to 9).
【0033】その他の界面活性剤として、次のようなも
のもある。天然界面活性剤、タンパク質加水分解物の誘
導体、高分子界面活性剤、チタン・ケイ素を含む界面活
性剤、フッ化炭素系界面活性剤。無機顔料としては、次
のようなものを例示することができる。オキシ塩化ビス
マス、カーボンブラック、カオリン、カラミン、クレ
ー、グンジョウ、ケイ酸マグネシウム、タルク、チタン
白、ベンガラ、ベントナイト、マイカ、リトポン、亜鉛
華、雲母チタン、黄酸化鉄、黒酸化鉄、酸化クロム、酸
化ジルコニウム、酸化チタン、酸化マグネシウム、酸化
亜鉛、水酸化クロム、炭酸カルシウム、炭酸マグネシウ
ム、無水ケイ酸、硫酸バリウム。紫外線吸収剤として
は、次のようなものを例示することができる。4−t−
ブチル−4´−メトキシ−ジベンゾイルメタン、アント
ラニル酸メチル、ウロカニン酸、ウロカニン酸エチル、
ウンベリフェロン、エスクリン;ケイ皮酸類[例えば、
4−メトキシケイ皮酸2−エチルヘキシル、4−メトキ
シケイ皮酸イソプロピル、4−メトキシケイ皮酸エチ
ル、4−メトキシケイ皮酸オクチル、4−メトキシケイ
皮酸ブチル、2,4−ジイソプロピルケイ皮酸メチル、
2,4−ジイソプロピルケイ皮酸エチル];サリチル酸
類[例えば、サリチル酸p−t−ブチルフェニル、サリ
チル酸p−オクチルフェニル、サリチル酸2−エチルヘ
キシル、サリチル酸チタン、サリチル酸フェニル、サリ
チル酸ホモメンチル、サリチル酸ミリスチル、サリチル
酸プロピレングリコール];ベンゾトリアゾール類[例
えば、2−[2−ヒドロキシ−3,5−ジ(t−ブチ
ル)フェニル]ベンゾトリアゾール、2−(2−ヒドロ
キシ−3−t−ブチル−5−メチルフェニル)ベンゾト
リアゾール、2−(2−ヒドロキシ−5−メチルフェニ
ル)ベンゾトリアゾール];ベンゾフェノン類[例え
ば、2,2´,4,4´−テトラヒドロキシベンゾフェ
ノン、2,2´−ジヒドロキシ−4,4´−ジメトキシ
ベンゾフェノン、2,2´−ジヒドロキシ−4−メトキ
シベンゾフェノン、2,4−ジヒドロキシベンゾフェノ
ン、2−ヒドロキシ−4−オクチルオキシベンゾフェノ
ン、2−ヒドロキシ−4−メトキシベンゾフェノン、2
−ヒドロキシ−4−メトキシベンゾフェノンスルホン
酸、オキシベンゾンスルホン酸、オキシベンゾンスルホ
ン酸(3水塩)、ジヒドロキシジメトキシベンゾフェノ
ンスルホン酸ナトリウム];パラアミノ安息香酸類(例
えば、パラアミノ安息香酸、パラアミノ安息香酸エチ
ル、パラアミノ安息香酸グリセリン、パラジメチルアミ
ノ安息香酸アミル、パラジメチルアミノ安息香酸エチ
ル、パラジメチルアミノ安息香酸オクチル)。抗酸化剤
としては、次のようなものを例示することができる。ア
スコルビン酸及びその塩、ゴシポール、ステアリン酸エ
ステル、セサモール、セサモリン、トコフェロール及び
そのエステル誘導体、ノルジヒドログアセレテン酸、パ
ラヒドロキシアニソール、ブチルヒドロキシアニソール
(BHA)、ブチルヒドロキシトルエン(BHT)、亜
硫酸ナトリウム、没食子酸プロピル。Other surfactants include the following. Natural surfactants, protein hydrolyzate derivatives, polymer surfactants, surfactants containing titanium / silicon, fluorocarbon surfactants. The following can be illustrated as an inorganic pigment. Bismuth oxychloride, carbon black, kaolin, calamine, clay, gunjou, magnesium silicate, talc, white titanium, red iron oxide, bentonite, mica, lithopone, zinc white, mica titanium, yellow iron oxide, black iron oxide, chromium oxide, oxidation Zirconium, titanium oxide, magnesium oxide, zinc oxide, chromium hydroxide, calcium carbonate, magnesium carbonate, silicic acid anhydride, barium sulfate. The following can be illustrated as an ultraviolet absorber. 4-t-
Butyl-4'-methoxy-dibenzoylmethane, methyl anthranilate, urocanic acid, ethyl urocanate,
Umbelliferone, esculin; cinnamic acids [eg,
4-Methylcinnamate 4-methoxy, Isopropyl 4-methoxycinnamate, Ethyl 4-methoxycinnamate, Octyl 4-methoxycinnamate, Butyl 4-methoxycinnamate, 2,4-Diisopropylcinnamate Methyl,
2,4-Diisopropylethyl cinnamate]; salicylic acids [eg pt-butylphenyl salicylate, p-octylphenyl salicylate, 2-ethylhexyl salicylate, titanium salicylate, phenyl salicylate, homomenthyl salicylate, myristyl salicylate, propylene glycol salicylate. ]; Benzotriazoles [eg, 2- [2-hydroxy-3,5-di (t-butyl) phenyl] benzotriazole, 2- (2-hydroxy-3-t-butyl-5-methylphenyl) benzotriazole , 2- (2-hydroxy-5-methylphenyl) benzotriazole]; benzophenones [eg, 2,2 ', 4,4'-tetrahydroxybenzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone] , 2, 2 ' -Dihydroxy-4-methoxybenzophenone, 2,4-dihydroxybenzophenone, 2-hydroxy-4-octyloxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2
-Hydroxy-4-methoxybenzophenone sulfonic acid, oxybenzone sulfonic acid, oxybenzone sulfonic acid (trihydrate), sodium dihydroxydimethoxybenzophenone sulfonate]; paraaminobenzoic acids (eg, paraaminobenzoic acid, ethyl paraaminobenzoate, glycerin paraaminobenzoate) , Amyl paradimethylaminobenzoate, ethyl paradimethylaminobenzoate, octyl paradimethylaminobenzoate). The following can be illustrated as an antioxidant. Ascorbic acid and its salts, gossypol, stearic acid ester, sesamol, sesamolin, tocopherol and its ester derivatives, nordihydroguaselethenoic acid, parahydroxyanisole, butylhydroxyanisole (BHA), butylhydroxytoluene (BHT), sodium sulfite, Propyl gallate.
【0034】抗炎症剤としては、次のようなものを例示
することができる。dl−α−トコフェロール及びその
誘導体、d又はdl−カンフル、アズレン、アセチルサ
リチル酸、イクタモール、インドメタシン、カマズレ
ン、グアイアズレン、グリチルリチン酸及びその塩(グ
リチルリチン酸ジカリウム)、グリチルレチン酸及びそ
の塩、グリチルレチン酸誘導体、サリチル酸、サリチル
酸ナトリウム、サリチル酸メチル、ヒドロコルチゾン、
ビタミンB2 及びB6 、マレイン酸クロルフェニラミ
ン、塩化リゾチーム、塩酸ジフェンヒドラミン、甘草エ
キス。殺菌・消毒薬としては、次のようなものを例示す
ることができる。アクリノール、イオウ、イソプロピル
メチルフェノ−ル、オルソメトキシシンナムアルデヒ
ド、クレゾール、グルコン酸クロルヘキシジン、スルフ
ァミン、セチルピリジニウム塩(塩化セチルピリジニウ
ム)、ソルビン酸、パラオキシ安息香酸エステル類(パ
ラオキシ安息香酸エチル、パラオキシ安息香酸プロピ
ル、パラオキシ安息香酸メチル)、パラクロロメタキシ
レノ−ル、ヒノキチオ−ル、ヒビテン、ベンザルコニウ
ム塩(塩化ベンザルコニウム)、ベンゼトニウム塩(塩
化ベンゼトニウム)、ラクトフェリン又はその加水分解
物、塩化デカリニウム、塩化メチルロザニリン。Examples of anti-inflammatory agents include the following. dl-α-tocopherol and its derivative, d or dl-camphor, azulene, acetylsalicylic acid, ictamol, indomethacin, chamazulen, guaiazulene, glycyrrhizinic acid and its salt (dipotassium glycyrrhizinate), glycyrrhetinic acid and its salt, glycyrrhetinic acid derivative, salicylic acid , Sodium salicylate, methyl salicylate, hydrocortisone,
Vitamin B2 and B6, chlorpheniramine maleate, lysozyme chloride, diphenhydramine hydrochloride, licorice extract. Examples of the sterilizing / disinfecting agents are as follows. Acrinol, sulfur, isopropylmethylphenol, orthomethoxycinnamaldehyde, cresol, chlorhexidine gluconate, sulfamine, cetylpyridinium salt (cetylpyridinium chloride), sorbic acid, paraoxybenzoic acid esters (ethyl paraoxybenzoate, propyl paraoxybenzoate) , Methyl paraoxybenzoate), parachlorometaxylenol, hinokitiol, hibitene, benzalkonium salt (benzalkonium chloride), benzethonium salt (benzethonium chloride), lactoferrin or its hydrolyzate, decalinium chloride, chloride Methyl rosaniline.
【0035】収斂剤としては、次のようなものを例示す
ることができる。p−フェノールスルホン酸亜鉛、アラ
ントイン、カラミン、クエン酸、コハク酸、タンニン
酸、バーチエクストラクト、ポリピロリドンカルボン酸
アルミニウム、レゾルシン、塩化アルミニウム、塩化亜
鉛、塩化第二鉄、酸化亜鉛、酒石酸、乳酸、硫酸アルミ
ニウムカリウム、硫酸亜鉛。頭髪用剤としては、次のよ
うなものを例示することができる。カンタリスチンキ、
ショウキョウチンキ、ジンクピリチオン、チアントー
ル、チオグリコール酸、トウガラシチンキ、ビフェナミ
ン、塩酸キニーネ、強アンモニア水、臭化アルキルイソ
キノリニウム液、臭素酸カリウム、臭素酸ナトリウム、
二硫化セレン。The following astringents can be exemplified. Zinc p-phenolsulfonate, allantoin, calamine, citric acid, succinic acid, tannic acid, birch extract, aluminum polypyrrolidonecarboxylate, resorcin, aluminum chloride, zinc chloride, ferric chloride, zinc oxide, tartaric acid, lactic acid, Aluminum potassium sulfate, zinc sulfate. The following can be illustrated as an agent for hair. Cantalis tincture,
Ginger deer tincture, zinc pyrithione, thiantol, thioglycolic acid, capsicum tincture, biphenamine, quinine hydrochloride, strong ammonia water, alkylisoquinolinium bromide solution, potassium bromate, sodium bromate,
Selenium disulfide.
【0036】本発明の食品、医薬品、医薬部外品及び、
化粧品に用いられる組成物は、本発明による有効成分で
ある泡盛をそのまま、水希釈物、もしくは、モレキュラ
ーシーブで、水やエタノールの一部を除いたもの等を用
いることができる。さらに、本発明による有効成分の効
果を損なわず、相加的もしくは相乗的に、より確実に効
果を発揮させるための物質を含む組成物に加工もしくは
製剤して使用することもできる。このような加工もしく
は製剤された組成物に含有させる泡盛の量は、エタノー
ル含有量45度の泡盛に換算して、0.1〜99.9
%、好ましくは、0.5〜80%である。加工もしくは
製剤された組成物は、泡盛の他に、所望する組成物に適
した物質を上述の例示物質の中から選び、更に必要なら
ば、その他の物質を適宜加えて調製することができる。
例えば、本発明による組成物の調製時に、抗アレルギー
有効性が認められているリノレン酸(α−リノレン酸、
γ−リノレン酸)、エゴマ油、月見草油、シソ精油など
を併用することが好ましい。また、保存中に他の成分を
化学変化させることが少なく、組成物の保存安定性に優
れている、非還元糖トレハロースの併用も好ましい。The food, drug, quasi drug of the present invention, and
As the composition used in cosmetics, awamori which is the active ingredient according to the present invention may be used as it is, or a water diluted product or a molecular sieve obtained by removing a part of water or ethanol. Further, it can be used by processing or formulation into a composition containing a substance for exerting the effect more reliably additively or synergistically without impairing the effect of the active ingredient according to the present invention. The amount of awamori contained in such a processed or formulated composition is 0.1 to 99.9 in terms of ethanol content of 45 degrees.
%, Preferably 0.5 to 80%. In addition to awamori, a processed or formulated composition can be prepared by selecting a substance suitable for the desired composition from the above-exemplified substances and, if necessary, adding other substances as appropriate.
For example, when preparing the composition according to the present invention, linolenic acid (α-linolenic acid, which is recognized to have antiallergic efficacy,
(γ-linolenic acid), perilla oil, evening primrose oil, perilla essential oil and the like are preferably used in combination. Further, it is also preferable to use the non-reducing sugar trehalose in combination, which is less likely to chemically change other components during storage and has excellent storage stability of the composition.
【0037】加工もしくは製剤された組成物に泡盛を含
有させる方法は、その組成物が完成するまでの工程で含
有させればよいので、例えば、混和、溶解、融解、浸
漬、浸透、散布、塗布、被覆、噴霧、注入、晶出、固化
など公知の方法が適宜選ばれる。本発明による組成物
中、食品及び、医薬品経口剤の1日あたりの摂取量は、
成人(体重60kgとして)で、水で希釈しエタノール
含有量35度に調製した泡盛に換算して、0.5〜50
cc、好ましくは、5〜40ccである。この量を、組
成物の形態に係わらず、1回もしくは、2回以上に分け
て摂取して差し支えない。食品及び、医薬品経口剤への
泡盛の含有量は、上記の摂取量が可能な範囲で適宜に選
ぶことができる。食品または、医薬品経口剤をアレルギ
ー症状が出る前から摂取すれば、予防効果を獲得でき、
発症後に摂取すれば、治療効果を獲得できる。摂取の時
期及び期間は、例えば、スギ花粉症の様に発症の時期
が、スギ花粉の飛散時期と重なっていて明かな場合に
は、その発症が予想される1週間〜3カ月前、好ましく
は、3週間〜3カ月前から摂取することにより、予防効
果を獲得することができる。予防的な摂取の後に、さら
に、スギ花粉の飛散開始後も本発明物の摂取を続けれ
ば、予防効果と合わさった治療効果により、発症が見ら
れないか、症状が著しく軽減される。これは他のアレル
ゲンについても同様である。上述のスギ花粉症において
獲得される効果は、目のかゆみ、痛みや充血等のアレル
ギー性結膜炎、くしゃみや鼻詰まり、鼻水等の鼻アレル
ギー症状の無発症もしくは、軽減効果である。本発明に
よる組成物中、医薬品非経口剤、医薬部外品及び、化粧
品の使用量及び、使用時期は、対象とする器官、予防目
的か治療目的か等により異なるが、概ねその使用量は、
多くても経口摂取量程度であり、例えば、軟膏剤の鼻
(下鼻甲介)への塗布や嗅剤のように局所に使用する場
合にはその使用量は少なくて済む。さらに、本発明によ
る組成物は、ヒトの他に、ラット、ウサギ、ヒツジ、ブ
タ、ウシ、ネコ、イヌ、サル等の温血哺乳動物に対して
も使用することができる。次に実施例により本発明をさ
らに具体的に説明するが、本発明はこれらの実施例に限
定されるものではない。The method of incorporating awamori into the processed or formulated composition may be such that it is included in the steps until the composition is completed. For example, mixing, dissolving, melting, dipping, penetrating, spraying, coating Known methods such as coating, spraying, pouring, crystallization, and solidification are appropriately selected. In the composition according to the present invention, the daily intake of food and pharmaceutical oral preparation is
As an adult (with a body weight of 60 kg), it is diluted with water and converted into an awamori prepared with an ethanol content of 35 degrees, which is 0.5 to 50.
cc, preferably 5 to 40 cc. This amount may be ingested once or divided into two or more doses regardless of the form of the composition. The content of awamori in foods and oral pharmaceutical preparations can be appropriately selected within the above-mentioned intake range. If you take food or oral medicines before the onset of allergic symptoms, you can get a preventive effect,
If taken after the onset, the therapeutic effect can be obtained. The timing and period of ingestion are, for example, 1 week to 3 months before the onset of the onset, preferably when the onset of onset such as Japanese cedar pollinosis overlaps with the time when the Japanese cedar pollen is scattered. A prophylactic effect can be obtained by ingesting from 3 weeks to 3 months ago. If the ingestion of the present invention is continued after the preventive ingestion and after the start of the scattering of the cedar pollen, the onset is not observed or the symptoms are remarkably reduced due to the therapeutic effect combined with the preventive effect. This also applies to other allergens. The effect obtained in the above-mentioned cedar pollinosis is the absence or alleviation of allergic conjunctivitis such as itchy eyes, pain and hyperemia, and nasal allergic symptoms such as sneezing and stuffy nose and runny nose. In the composition according to the present invention, the amount of parenteral drug, quasi drug, and cosmetic used and the timing of use vary depending on the target organ, preventive purpose or therapeutic purpose, etc.
At most, it is about an oral intake amount, and for example, when the ointment is applied to the nose (lower turbinate) or is used locally such as an olfactory agent, the use amount is small. Further, the composition according to the present invention can be used not only for humans but also for warm-blooded mammals such as rat, rabbit, sheep, pig, cow, cat, dog and monkey. Next, the present invention will be described more specifically by way of examples, but the present invention is not limited to these examples.
【0038】[0038]
【実施例】以下の実施例において、いずれも、請福酒造
有限会社製、泡盛古酒(5年貯蔵。エタノール含有量3
5度)「請福(登録商標)」を使用した。 試験例1 20年来、スギ花粉の飛散時期になると、クシャミ、鼻
水、眼のカユミ等のスギ花粉症の症状を呈している被験
者(成人男性)に、例年スギ花粉の飛散が始まるほぼ1
カ月前から、泡盛15ml/回を毎日朝夕服用させた。
服用は、スギ花粉の飛散の注意報がなされなくなるまで
行ったが、食事をはじめ生活には特に制限はしなかっ
た。服用後、1カ月経過後から、被験者の毎日の自覚症
状をもとに予防効果及び、治療効果の判定を行った。ス
ギ花粉の飛散の注意報が報じられている期間のいずれの
時点においても例年よりも症状が著しく軽減された。ま
た、スギ花粉の飛散最盛期にあたる、服用開始後50〜
60日目の自覚症状は、当日服用により著しく軽減され
た。[Examples] In the following examples, Awamori old liquor (stored for 5 years. Ethanol content 3
(5 times) "Choufu (registered trademark)" was used. Test Example 1 For 20 years, at the time when the cedar pollen was scattered, almost 1 year after the cedar pollen started to be dispersed to a subject (adult male) who exhibited symptoms of cedar pollinosis such as sneezing, runny nose, and eye itch.
From a month ago, 15 ml of awamori was administered daily in the morning and evening.
The drug was taken until the warning about the scattering of cedar pollen was not given, but there were no particular restrictions on diet and other lifestyles. One month after the administration, the preventive effect and the therapeutic effect were evaluated based on the subject's daily subjective symptoms. Symptoms were significantly less than usual at any time during the period when the warning for the scattering of Japanese cedar pollen was reported. In addition, after the start of administration, which is at the peak of the scattering of cedar pollen,
The subjective symptoms on the 60th day were markedly reduced by taking the same day.
【0039】試験例2 10年来、スギ花粉の飛散時期になると、クシャミ、鼻
水、眼のカユミ等のスギ花粉症の症状を呈している被験
者(成人男性)に、スギ花粉の飛散の注意報が報じら
れ、自覚症状が認められて、3日後から、泡盛15ml
/回を毎日朝夕服用させた。服用は、スギ花粉の飛散の
注意報がなされなくなるまで行ったが、食事をはじめ生
活には特に制限はしなかった。服用日から、被験者の毎
日の自覚症状をもとに治療効果の判定を行った。服用後
1〜2時間経過後から、明かな、症状の軽減効果が10
時間程度継続するのが自覚された。この軽減効果は、ス
ギ花粉の飛散最盛期においても認められた。Test Example 2 At the time when cedar pollen was scattered for 10 years, a warning (sculpture of cedar pollen) was given to a subject (adult man) exhibiting symptoms of cedar pollinosis such as sneezing, runny nose, and eye itch. It was reported that 3 days after the subjective symptoms were recognized, 15 ml of awamori
I took it every morning and evening. The drug was taken until the warning about the scattering of cedar pollen was not given, but there were no particular restrictions on diet and other lifestyles. From the day of administration, the therapeutic effect was judged based on the daily subjective symptoms of the test subjects. From 1 to 2 hours after taking the drug, a clear symptom-relieving effect is 10
I was aware that it would continue for about an hour. This mitigation effect was also observed during the peak period of cedar pollen scattering.
【0040】調製例1 フルーツゼリーの調製 鍋にグラニュー糖(精製した蔗糖の一種)100gと水
300gとを入れて、加熱し溶液にした。ついで、加熱
をやめた溶液に、粉状のゼラチン12gを水でふやかし
たものを加えて溶かした。この混合物を氷水で冷却し、
混合物の温度が室温になったところで、泡盛50gとレ
モン汁2分の1個分を加えた。さらに冷却を続け、水温
になったところで、最も長い辺が1.5cm程度に乱切
りしたイチゴ、オウトウ、メロン各々40g、計120
gを加えて、とろみが付くまで混ぜ合わせた。ついで、
混合物をほぼ4等分して、容器に入れて、冷蔵庫で固ま
るまで冷やし、泡盛を含有したフルーツゼリーを調製し
た。Preparation Example 1 Preparation of Fruit Jelly 100 g of granulated sugar (a kind of purified sucrose) and 300 g of water were put in a pan and heated to form a solution. Then, 12 g of powdered gelatin moistened with water was added to the solution whose heating was stopped to dissolve it. The mixture is cooled with ice water,
When the temperature of the mixture reached room temperature, 50 g of awamori and 1/2 of lemon juice were added. When the water temperature is reached by further cooling, the longest side is chopped into 1.5 cm pieces of strawberries, sweet cherry and melon, each weighing 40 g, for a total of 120
g was added and mixed until thick. Then
The mixture was divided into approximately 4 equal parts, placed in a container, and cooled in a refrigerator until they solidified to prepare fruit jelly containing awamori.
【0041】調製例2 レモンシャーベットの調製 レモン4個分の果汁、グラニュー糖(精製した蔗糖の一
種)100gと40℃の水200gをボールに入れてよ
く混ぜ合わせ、グラニュー糖が溶けたら、泡盛30gを
加えて混ぜ合わた後、ラップをして、冷凍庫に入れた。
全体が固まりかけたら、泡立て器でよく泡立て、再びラ
ップをして冷凍庫に入れた。この操作を5回繰り返し
た。ついで、混合物をほぼ4等分して、容器に入れて、
冷凍庫で凍らせて、泡盛を含有したレモンシャーベット
を調製した。Preparation Example 2 Preparation of Lemon Sorbet 100 g of fruit juice for 4 lemons, 100 g of granulated sugar (a kind of refined sucrose) and 200 g of water at 40 ° C. were put in a bowl and mixed well, and when the granulated sugar was dissolved, 30 g of awamori Was added and mixed, wrapped and wrapped in a freezer.
When the whole was about to solidify, whisk well with a whisk, rewrap and put in the freezer. This operation was repeated five times. Then, divide the mixture into four equal parts, put them in a container,
A lemon sherbet containing awamori was prepared by freezing in a freezer.
【0042】調製例3 焼肉のタレの調製 醤油、泡盛各大さじ2、ゴマ油、砂糖、リンゴ汁各大さ
じ1、すりゴマ大さじ1.5、ニンニク1片、片栗粉小
さじ1、月見草油小さじ1、コショウ少々、粉トウガラ
シ少々をよく混ぜ合わせ、泡盛を含有した焼肉のタレを
調製した。Preparation Example 3 Preparation of Sauce of Roasted Meat Soy sauce, 2 tablespoons of awamori, 1 tablespoon of sesame oil, sugar, apple juice, 1 tablespoon of ground sesame seeds, 1 piece of garlic, 1 teaspoon of starch starch, 1 teaspoon of evening primrose oil, a little pepper , A small amount of powdered capsicum were mixed well to prepare a sauce of roasted meat containing awamori.
【0043】調製例4 南蛮酢の調製 だし汁1カップ、醤油0.5カップ、酢0.3カップ、
砂糖大さじ2、みりん大さじ1をひと煮立ちさせ、泡盛
0.25カップとトウガラシ1本を加えて、泡盛を含有
した南蛮酢を調製した。Preparation Example 4 Preparation of Nanban vinegar 1 cup of soup stock, 0.5 cup of soy sauce, 0.3 cup of vinegar,
2 tablespoons of sugar and 1 tablespoon of mirin were boiled and added with 0.25 cups of awamori and 1 capsicum to prepare nanban vinegar containing awamori.
【0044】調製例5 紅茶飲料の調製 ( 組 成 ) (g) 泡盛 7.0 グラニュー糖 8.0 香 料 0.1 食 塩 0.05 紅茶抽出水 A) 84.8 上記の5成分を均一に混ぜ合わせて、泡盛を含有した紅
茶飲料を調製した。 A) テイーバックの紅茶を熱湯100ccで抽出し、氷
片を加えて、200ccとしたもの。Preparation Example 5 Preparation of Black Tea Beverage (Composition) (g) Awamori 7.0 Granulated Sugar 8.0 Flavor 0.1 Food Salt 0.05 Black Tea Extract Water A) 84.8 The above 5 components are homogeneous To prepare a black tea beverage containing awamori. A) Teabag black tea was extracted with 100 cc of hot water and ice pieces were added to make 200 cc.
【0045】調製例6 ジュースの調製 (組 成) (g) 泡盛 3.0 冷凍濃縮温州みかん果汁 5.0 果糖ブドウ糖液糖 11.0 ク エ ン 酸 0.2 L−アスコルビン酸 0.02 香 料 0.2 色 素 0.1 水 80.48 上記の9成分を均一に混ぜ合わせて、泡盛を含有したジ
ュースを調製した。Preparation Example 6 Preparation of juice (composition) (g) Awamori 3.0 Frozen concentrated Unshu mandarin orange juice 5.0 Fructose glucose liquid sugar 11.0 Quenoic acid 0.2 L-Ascorbic acid 0.02 Fragrance Food 0.2 color 0.1 Water 80.48 The above 9 components were uniformly mixed to prepare a juice containing awamori.
【0046】調製例7 注射液の調製 泡盛を3gに精製水を加えて全量を200gとして、ミ
リポアフィルターGSタイプを用いて、除菌して注射液
を調製した。Preparation Example 7 Preparation of Injectable Solution 3 g of awamori was added to purified water to make the total amount 200 g, and bacteria were sterilized using a Millipore filter GS type to prepare an injectable solution.
【0047】調製例8 膏薬剤の調製 トレハロース200g及びマルトース300gに、泡盛
50gを加え混合し、更に10%プルラン水溶液200
gを加えて混合し、適度の延び、付着性を示す膏薬剤を
調製した。Preparation Example 8 Preparation of plaster drug To 200 g of trehalose and 300 g of maltose, 50 g of Awamori was added and mixed, and 200% of 10% pullulan aqueous solution was added.
g was added and mixed to prepare a plaster drug exhibiting a proper extension and adhesiveness.
【0048】調製例9 軟膏剤の調製 プロピレングリコール70gとポリエチレングリコール
14gを60℃で加温溶解し、撹拌しながら、泡盛25
gとベンジルアルコール1gを徐々に添加し、30℃ま
で撹拌した後、自然冷却して軟膏剤を調製した。Preparation Example 9 Preparation of Ointment 70 g of propylene glycol and 14 g of polyethylene glycol were dissolved by heating at 60 ° C., and awamori 25 was added while stirring.
g and benzyl alcohol 1 g were gradually added, and the mixture was stirred to 30 ° C. and then naturally cooled to prepare an ointment.
【0049】調製例10 軟膏剤の調製 泡盛37g、スクワラン20g、グリセリン20g、セ
チルアルコール5g、マグネシウムステアレート3g及
び、プロピレングリコール5gを均一に混合し、軟膏剤
を調製した。Preparation Example 10 Preparation of Ointment An ointment was prepared by uniformly mixing 37 g of awamori, 20 g of squalane, 20 g of glycerin, 5 g of cetyl alcohol, 3 g of magnesium stearate and 5 g of propylene glycol.
【0050】調製例11 ローション剤の調製 グリセリン5gとアルギン酸プロピレングリコール0.
2gの混合物に、攪拌下、泡盛25gにポリオキシエチ
レンセチルエーテル(20EO)1gを溶かした後、精
製水68.8gを加えて得られる混合物を小量ずつ加え
て、ローション剤を調製した。Preparation Example 11 Preparation of lotion 5 g of glycerin and propylene glycol alginate
To 2 g of the mixture, 1 g of polyoxyethylene cetyl ether (20EO) was dissolved in 25 g of awamori while stirring, 68.8 g of purified water was added, and the resulting mixture was added little by little to prepare a lotion.
【0051】調製例12 化粧水の調製 グリセリン5gとポリオキシエチレンヒマシ油誘導体
0.5gの混合物に、攪拌下、泡盛20g、ソルビトー
ル3g、アラントイン0.1gと精製水71.4gとの
混合物を小量ずつ加えて、化粧水を調製した。Preparation Example 12 Preparation of lotion To a mixture of 5 g of glycerin and 0.5 g of polyoxyethylene castor oil derivative, a mixture of 20 g of awamori, 3 g of sorbitol, 0.1 g of allantoin and 71.4 g of purified water was stirred into a small amount. A lotion was prepared by adding each amount.
【0052】調製例13 乳液の調製 精製水48.4gにジプロピレングリコール5gを加
え、加熱撹拌し、温度を60℃に保持し、これに、クイ
ンスシードガム5%水溶液15g、香料0.3g、ステ
アリン酸1.3g、セタノール0.7g、ミツロウ2.
0g、ポリオキシエチレン(11)モルオレイン酸エス
テル1.2g、グリセリンモノステアリン酸エステル
0.8g及び、メチルパラベン0.3gを加えて撹拌
し、次に、ホモジナイザーで均一に乳化させた。得られ
た乳化液を冷却しながら撹拌下に、泡盛25gを徐々に
加え、室温に冷却して乳液を調製した。Preparation Example 13 Preparation of Emulsion 5 g of dipropylene glycol was added to 48.4 g of purified water, heated and stirred, and the temperature was maintained at 60 ° C., to which 15 g of quince seed gum 5% aqueous solution, 0.3 g of fragrance, Stearic acid 1.3 g, cetanol 0.7 g, beeswax 2.
0 g, 1.2 g of polyoxyethylene (11) mol oleate, 0.8 g of glycerin monostearate and 0.3 g of methyl paraben were added and stirred, and then uniformly emulsified with a homogenizer. While cooling the obtained emulsion, 25 g of Awamori was gradually added with stirring and cooled to room temperature to prepare an emulsion.
【0053】調製例14 ヘアトニックの調製 泡盛70g、水27g、ポリオキシエチレン(40)硬
化ヒマシ油2gとオレイン酸エチル1gを均一に混合し
て、ヘアトニックを調製した。Preparation Example 14 Preparation of Hair Tonic A hair tonic was prepared by uniformly mixing 70 g of awamori, 27 g of water, 2 g of polyoxyethylene (40) hydrogenated castor oil and 1 g of ethyl oleate.
【0054】調製例15 ヘアトニックの調製 泡盛40gとエタノール57.3gとの混合物に、セン
ブリエキス0.3g、ヒノキチオール0.025g、ビ
タミンEアセテート0.2g、L−メントール0.0
6、D−パントテニルエチルエーテル0.35g、β−
グリチルレチン酸0.1g、ラウリル硫酸ナトリウム
0.1g、ニコチン酸アミド0.1g、ヒドロキシプロ
ピルセルロース0.6g、ポリビニルピロリドン0.2
g及び、α,α−トレハロース0.7gを加えて均一に
混合して、ヘアトニックを調製した。Preparation Example 15 Preparation of Hair Tonic A mixture of 40 g of Awamori and 57.3 g of ethanol was added to 0.3 g of Assemblage extract, 0.025 g of hinokitiol, 0.2 g of Vitamin E acetate and 0.0 of L-menthol.
6, D-pantothenyl ethyl ether 0.35 g, β-
Glycyrrhetinic acid 0.1 g, sodium lauryl sulfate 0.1 g, nicotinic acid amide 0.1 g, hydroxypropyl cellulose 0.6 g, polyvinylpyrrolidone 0.2
and 0.7 g of α, α-trehalose were added and mixed uniformly to prepare a hair tonic.
【0055】調製例16 ヘアエッセンス剤の調製 泡盛20gと水72.5gとの混合物に、朝鮮人参エキ
ス2.0g、ハッカ油0.01g、D−パントテニルア
ルコール0.25g、グリチルリチン酸ジカリウム0.
1g、パラオキシ安息香酸メチル0.1g、パラオキシ
安息香酸プロピル0.025g、ポリビニルアルコール
1.25g、カルボキシメチルセルロースナトリウム塩
0.75g、ポリビニルピロリドン0.05g及び、
α,α−トレハロース3.0gを加えて均一に混合し
て、ヘアエッセンス剤を調製した。Preparation Example 16 Preparation of Hair Essence Agent A mixture of 20 g of awamori and 72.5 g of water was added to 2.0 g of ginseng extract, 0.01 g of peppermint oil, 0.25 g of D-pantothenyl alcohol, and 0.25 g of dipotassium glycyrrhizinate.
1 g, methyl paraoxybenzoate 0.1 g, propyl paraoxybenzoate 0.025 g, polyvinyl alcohol 1.25 g, carboxymethylcellulose sodium salt 0.75 g, polyvinylpyrrolidone 0.05 g, and
3.0 g of α, α-trehalose was added and uniformly mixed to prepare a hair essence agent.
【0056】調製例17 シャンプーの調製 泡盛25g、精製水21g、ラウリルポリオキシエチレ
ン(3モル)硫酸エステルトリエタノールアミン塩(4
0%水溶液)30g、ラウリルポリオキシエチレン(3
モル)硫酸エステルナトリウム塩(40%水溶液)20
g及び、ラウロイルジエタノールアミド4gを均一に混
合して、シャンプーを調製した。Preparation Example 17 Preparation of shampoo 25 g of awamori, 21 g of purified water, lauryl polyoxyethylene (3 mol) sulfuric acid ester triethanolamine salt (4
0% aqueous solution) 30 g, lauryl polyoxyethylene (3
Mol) sulfate sodium salt (40% aqueous solution) 20
g and 4 g of lauroyl diethanolamide were uniformly mixed to prepare a shampoo.
【0057】調製例18 ボデイーソープの調製 泡盛15g、精製水60g、ラウリン酸カリウム15
g、ミリスチン酸カリウム5g、プロピレングリコール
5g、シソ精油0.05g及び、ヒノキチオール0.0
5gを均一に混合して、ボデイーソープを調製した。Preparation Example 18 Preparation of body soap 15 g of awamori, 60 g of purified water, 15 potassium laurate
g, potassium myristate 5 g, propylene glycol 5 g, perilla essential oil 0.05 g, and hinokitiol 0.0
A body soap was prepared by uniformly mixing 5 g.
【0058】調製例19 入浴剤の調製 硫酸ナトリウム2g、炭酸水素ナトリウム2g、塩化ナ
トリウム2g及び、α,α−トレハロース2gを精製水
62gに溶かした。ついで、この溶液に泡盛30g及
び、バジル精油0.05gを加えて、入浴剤を調製し
た。Preparation Example 19 Preparation of Bath Salt 2 g of sodium sulfate, 2 g of sodium hydrogen carbonate, 2 g of sodium chloride and 2 g of α, α-trehalose were dissolved in 62 g of purified water. Then, 30 g of awamori and 0.05 g of basil essential oil were added to this solution to prepare a bath agent.
【0059】[0059]
【発明の効果】本発明者らは、アルコール性飲料として
その性質が周知されている泡盛が抗アレルギー有効成分
として利用できることを見いだした。したがって、本発
明による泡盛を含有する食品、医薬品、医薬部外品及
び、化粧品は、アレルギー性疾患の予防及び治療に利用
することができる。EFFECTS OF THE INVENTION The present inventors have found that awamori, whose properties are well known as alcoholic beverages, can be used as an antiallergic active ingredient. Therefore, the food, drug, quasi drug and cosmetic containing the awamori according to the present invention can be used for the prevention and treatment of allergic diseases.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 7/48 A61K 7/48 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification code Agency reference number FI Technical display location A61K 7/48 A61K 7/48
Claims (4)
品。1. A food containing awamori as an antiallergic active ingredient.
品。2. A pharmaceutical product containing awamori as an antiallergic active ingredient.
部外品。3. A quasi drug containing awamori as an antiallergic active ingredient.
品。4. A cosmetic containing awamori as an antiallergic active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8153162A JPH09315987A (en) | 1996-05-24 | 1996-05-24 | Utilization of awamori as antiallergic active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8153162A JPH09315987A (en) | 1996-05-24 | 1996-05-24 | Utilization of awamori as antiallergic active ingredient |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09315987A true JPH09315987A (en) | 1997-12-09 |
Family
ID=15556405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8153162A Pending JPH09315987A (en) | 1996-05-24 | 1996-05-24 | Utilization of awamori as antiallergic active ingredient |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH09315987A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002533399A (en) * | 1998-12-28 | 2002-10-08 | アラジー リミテッド エルエルシー | Method of treating cyanocobalamin (vitamin B12) for allergic diseases |
WO2003101460A1 (en) * | 2002-06-03 | 2003-12-11 | Cac Corporation | External preparations for treating dermatitis |
JP2005080532A (en) * | 2003-09-05 | 2005-03-31 | Pola Chem Ind Inc | Food composition |
JP2007510716A (en) * | 2003-11-07 | 2007-04-26 | オーキー ナチュラル カンパニー,リミテッド | Pharmaceutical composition containing guaiacol component and syringol component extracted from wood vinegar |
JP2008022794A (en) * | 2006-07-24 | 2008-02-07 | Yaegaki Hakko Giken Kk | Functional food and method for producing the same |
JP2013100270A (en) * | 2011-10-21 | 2013-05-23 | Taisho Pharmaceutical Co Ltd | Galenical extract-containing liquid composition |
JP2020000033A (en) * | 2018-06-26 | 2020-01-09 | 国立大学法人広島大学 | Oral immune tolerance inducing agent, food and medicament containing the same, and process for producing processed food |
-
1996
- 1996-05-24 JP JP8153162A patent/JPH09315987A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002533399A (en) * | 1998-12-28 | 2002-10-08 | アラジー リミテッド エルエルシー | Method of treating cyanocobalamin (vitamin B12) for allergic diseases |
WO2003101460A1 (en) * | 2002-06-03 | 2003-12-11 | Cac Corporation | External preparations for treating dermatitis |
AU2002355005B2 (en) * | 2002-06-03 | 2006-04-13 | Cac Corporation | External preparations for treating dermatitis |
US7897161B2 (en) | 2002-06-03 | 2011-03-01 | Cac Corporation | External medicine for treating dermatitis |
JP2005080532A (en) * | 2003-09-05 | 2005-03-31 | Pola Chem Ind Inc | Food composition |
JP2007510716A (en) * | 2003-11-07 | 2007-04-26 | オーキー ナチュラル カンパニー,リミテッド | Pharmaceutical composition containing guaiacol component and syringol component extracted from wood vinegar |
JP2008022794A (en) * | 2006-07-24 | 2008-02-07 | Yaegaki Hakko Giken Kk | Functional food and method for producing the same |
JP2013100270A (en) * | 2011-10-21 | 2013-05-23 | Taisho Pharmaceutical Co Ltd | Galenical extract-containing liquid composition |
JP2020000033A (en) * | 2018-06-26 | 2020-01-09 | 国立大学法人広島大学 | Oral immune tolerance inducing agent, food and medicament containing the same, and process for producing processed food |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3966922B2 (en) | Fibroblast growth promoter | |
DE69919287T2 (en) | Ethyl acetate extract of indigo plant | |
JP3966924B2 (en) | Fibroblast growth promoter containing plant extract | |
JPH1053532A (en) | Antiallergic drug containing plant extract | |
JP4104180B2 (en) | Lipase activity promoter | |
JP2002138045A (en) | Inhibitor for inhibiting differentiation induction of pre- adipocyte | |
JPH1036279A (en) | Fibroblast proliferation promoting agent containing vegetable extract | |
JPH11106336A (en) | Maillard reaction inhibitor | |
JP2009108065A (en) | Polylysine preparation and cosmetic composition containing the same | |
JPWO2005072684A1 (en) | Maca extract manufacturing method | |
JPH09110710A (en) | Dermal preparation for external use and bathing agent | |
JPH08325156A (en) | Skin preparation for external use, drink and food product containing steviol glycoside | |
JPH09157176A (en) | Antiallergic agent containing extract of hypericum erectum thunb. and tilia miqueliana maxim. | |
JP2004131431A (en) | Composition for preventing or ameliorating ultraviolet damage | |
JP2002138044A (en) | Inhibitor for inhibiting differentiation induction of pre- adipocyte | |
JP2006174844A (en) | Steviol glycoside-containing food and drink | |
JPH11139986A (en) | Physiologically active composition derived from hydrolyzate of silk protein | |
JP2000143524A (en) | Antiinflammatory agent containing extract of amaranthus | |
JPH09194385A (en) | Antiallergic agent and preparation for external use for skin or bathing agent blended with the same agent | |
JP2005179308A (en) | Antiallergy composition | |
JPH0987188A (en) | Skin preparation for external use and bathing agent | |
JPH09315987A (en) | Utilization of awamori as antiallergic active ingredient | |
JP2000281528A (en) | Cosmetic composition | |
JP2003137801A (en) | Collagen production promoter, collagenase inhibitor, fibroblast cell-propagating agent, skin cosmetic material and food or beverage for cosmetic use | |
JPH10234319A (en) | Propolis extract-containing composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20050922 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060725 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060925 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080902 |